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ABSTRACT 
Mitochondrial Diseases (MD) are disorders of function in cellular oxidative 
phosphorylation caused by diverse nuclear DNA and mtDNA mutations and seen in 1/5,000 
births.  The purpose of this study was to examine relationships across medical indices, 
biochemical measures, and neurobehavioral functioning in children with MD.  Findings from 
Western Blot, Native Gels, High Resolution Respirometry, and the Nijmegen diagnostic criteria 
were assessed in relation to children’s processing speed and attention, based on the prediction 
that impaired functioning of proteins, complexes, and cellular respiration, that are critical in ATP 
production, will impact neurodevelopment and related neuropsychological processes in children 
with MD.  Twenty-five children (ages 4-13) were administered subtests from the DAS-II and 
NEPSY-II.  Results from multiple regression analyses suggest that processing speed and 
attention deficits may be markers of abnormal protein expression that interferes with the 
production of ATP in the oxidative phosphorylation process; implications for future research are 
presented. 
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CHAPTER 1 
 INTRODUCTION 
 
Mitochondrial Disease (MD), also referred to as Oxidative Phosphorylation (oxphos) 
Disease, is caused by abnormalities in the metabolic process by which an insufficient amount of 
adenosine triphosphate (ATP) is produced in the mitochondria (Shoffner, 1996).  Because ATP 
is a stored chemical energy that is used for many cellular processes that require energy, such as 
biosynthesis, locomotion, or transportation of molecules across cell membranes, MD is usually 
characterized by dysfunction  in organ systems, such as the brain and muscles, that have high 
dependency on the oxidative phosphorylation process for energy (Marcinek, 2004).  Since a case 
of MD was first recognized in 1962, this disease is now reported to be the most common inborn 
error of metabolism with an estimated frequency of one in 5,000 live births (Thorburn, 2004).  
However, even this report is most likely an underestimate of the actual prevalence, as many 
patients with MD are never referred for evaluation and symptoms are often nonspecific and can 
be disguised as other diseases (Zeviani, Bertagnolio, & Uziel, 1996).   
Several hundred variations of MD are classified primarily based on shared clinical 
presentations.  The subtypes of this disease can be classified as 1) myopathic, which includes 
Chronic Progressive External Ophthalmoplegia (CPEO) and Kearns Sayre syndrome (KSS), or 
2) encephalomyopathic, such as Mitochondrial Encephalomyopathy with Lactic Acidosis and 
Stroke-like Episodes (MELAS), Myoclonic Epilepsy with Ragged-red Fibers (MERRF), and 
Leigh Syndrome (LS).   Symptoms associated with the muscle (myopathy), brain 
(encephalopathy), or both (encephalomyopathy) are largely attributable to the high dependency 
of the muscle and brain on the oxidative phosphorylation  process for energy (Leonard & 
Schapira, 2000).  For instance, the central nervous system findings include fluctuating 
2 
 
encephalopathy, seizures, stroke-like episodes, mental retardation, dementia, migraine, ataxia, 
and spasticity (Thorburn, 2004).  Myopathic symptoms include hypotonia, exercise intolerance, 
cardiomyopathy, and muscle pain and weakness. Given that the development and function of all 
organ systems are dependent on energy, it is not surprising that MD can also cause ocular, 
vestibular, hepatic, cardiac, renal, gastrointestinal, endocrine, and hematological malfunctions.    
A critical problem in doing research in MD is the difficulty quantifying the clinical 
manifestations in the patient population due to the large spectrum of symptoms presented. The 
diverse presentation of disease onset, severity, system involvement, and outcome makes 
diagnosing and predicting the course of the disease challenging (Chinnery et al., 2000).  Despite 
the frequent clinical reports of brain abnormalities and cognitive deficits associated with MD, 
surprisingly only a few studies have evaluated the psychological and neuropsychological profiles 
of patients with MD.  At this time, there is little known about which characteristics of the disease 
best predict cognition and general neurobehavioral functioning, or progression of the disease 
over time (Drummond, 1998; Finsterer, 2006a; Gire et al., 2002; Morava et al., 2006).   
Since the discovery of MD about 50 years ago, many researchers have attempted to 
understand this disease, mostly through biochemical and genetic studies.  Several genetic 
mutations have been identified that are associated with specific clinical profiles (e.g., MELAS, 
LS, LHON, and MERRF).  However, these mutations are not necessarily predictive of their 
phenotypes and only serve to confirm a diagnosis that has been made through multiple methods 
of assessments.  Furthermore, although abnormalities in certain brain regions have been linked 
with MD, there is little empirical evidence elucidating how the biochemical abnormalities of MD 
lead to the brain abnormalities that affect cognition in this population.  However, based on 
maturational theories of brain development, and what is known about brain metabolic activity 
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from infancy to early childhood, it appears that subcortical and cerebellar areas in the brains, and 
related white matter connections, are more likely to be interrupted in early-onset MD.  Given the 
neuropsychological sequelae observed in other subcortical and white matter diseases and related 
brain insults in infancy and early childhood, it is suggested that children with MD should also 
exhibit deficits in processing speed and attention, which could underlie the delays or deficits in 
higher order executive functions reported in some cases of MD.  
 Diagnostic Criteria, Biochemistry, and Laboratorial Indices of MD 
A challenge in conducting research in MD is the difficulty of finding a relationship 
pattern among the large spectrum of clinical symptoms presented in this patient population.  
While some individuals identified with MD display a set of clinical features that fall into a 
defined clinical syndrome, many individuals do not.  MD may only affect a single organ, such as 
the eye in Leber Hereditary Optic Neuropathy (LHON), or may involve multiple organ systems 
and present with a variety of neurological and myopathic features.  In general, clinicians consider 
MD for diagnosis when at least two organ systems are affected that cannot be explained by other 
diseases (Shoffner, 2008).   
Given the low diagnostic success rate of mutation analysis and lack of agreement on what 
are optimal biochemical assays and cut-off lab values, a few different screening scoring systems 
are used to aid in the diagnosis of patients suspected to have MD.  One such diagnostic screening 
system is the Nijmegen Criteria for Mitochondrial Disease, which was developed by Morava and 
colleagues (2006) to compare children with established mtDNA or nDNA mutations with other 
children with non-mitochondrial multisystem disorders.  Points are assigned based on 1) 
neuromuscular presentation (opthalmoplegia, facies myopathica, exercise intolerance, muscle 
weakness, rhabdomyolysis), 2) CNS presentations (developmental delays, loss of skills, stroke-
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like episode, migraine, seizures, myoclonus, cortical blindness, pyramidal signs, extrapyramidal 
signs, brainstem involvement), 3) multisystem disease (hematology, GI tract, endocrine/growth, 
heart, kidney, vision, hearing, neuropathy, recurrent/familial), 4) metabolic and imaging studies 
(elevated lactate, L/P ratio, alanine, CSF lactate, CSF protein, CSF alanine, urinary TA 
excretion, ethylmalonic aciduria, stroke-like picture, Leigh syndrome), and 5) tissue morphology 
(ragged red/blue fibers, COX-negative fibers, SDH positive blood vessels, abnormal 
mitochondrial) (Morava et al., 2006).  The specific criteria are provided in Appendix A.             
Morava and colleagues (2006) found that all children with genetically established 
diagnoses of MD had a mitochondrial disease score above 6 (probable mitochondrial disorder) 
on the Nijmegen, whereas 73% of the children had a score above 8 (definite mitochondrial 
disorder) when the disease was confirmed through a muscle biopsy.  In the non-mitochondrial 
multisystem disorder group, the score was significantly lower, and no patients reached a score 
comparable to a definite disorder.  Although this scoring system was found to be insufficient for 
providing a definite diagnosis, the researchers suggested that it can, at least, screen out low-risk 
groups and prevent unnecessary muscle biopsy from being performed on children (Morava et al., 
2006).      
  Other major clinical classification systems for MD include the Modified Walker Criteria 
for Mitochondrial Disease Diagnosis (Bernier et al., 2002), Nonaka Criteria for Mitochondrial 
Encephalomyopathy (Nonaka, 2002), and Wolfson Criteria for Mitochondrial Disease 
(Nissenkorn et al., 1999).  Although the point assignment differs based on the approach, they all 
focus on identifying mitochondrial clinical phenotypes, Oxphos enzyme deficiency, abnormal 
mitochondrial ultrastructure, tissue morphology, neuromuscular manifestations, organ system 
involvement, and metabolic irregularities.  Because there is so little consensus on how to 
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systematically diagnose MD, some medical professionals have opted to use a more traditional, 
individualized approach for clinically evaluating mitochondrial dysfunction.  This process still 
involves taking family history of MD, physical and neurological examinations, routine and 
special laboratory tests, and histochemical and biochemical results of muscle biopsy for classic 
signs and patterns of the disease (Dimauro, Tay, & Mancuso, 2004).        
As mentioned, it is usually necessary to do a muscle biopsy to analyze the enzymatic 
structure and function of the oxidative phosphorylation process, regardless of which clinical 
classification system or individualized approach is used to diagnose a patient with MD. 
Oxidative phosphorylation is the terminal process of cellular respiration during which electrons 
are transferred to molecular oxygen through a series of protein complexes located in the inner 
mitochondrial membrane (Leonard & Schapira, 2000).  Complexes I through IV are responsible 
for establishing a proton gradient across the mitochondrial membrane.  Abnormalities in the 
oxidative phosphorylation process can interfere with the  metabolic pathways, such as glycolysis, 
pyruvate metabolism, the tricarboxylic acid cycle, protein catabolism, and fatty acid oxidation 
(Shoffner, 2008). Appendix B provides greater detail about the individual roles the different 
genes, proteins, and complexes play in the production of ATP in the mitochondria.    
One laboratory tool that is commonly used for diagnosis is the Western Blot, which is a 
method used to assess the integrity of the Oxphos enzymes in a tissue sample (Capaldi, Murray, 
Byrne, Janes, & Marusich, 2004).  Another method is the Natives Gels, which are separation 
methods with high resolution. These methods can be used to analyze the size, relative 
abundance, and subunit composition of multiprotein complexes (Swarmy et al., 2006).  The Blue 
Native Gel is used best to visualize the Supercomplex and Complexes III to V, whereas the Clear 
Native Gel can be used for Complexes I and II.  The combination of Blue Native and Clear 
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Native Gels is an effective method for detecting altered assembly of Oxphos complexes (Bart 
Devreese, 2002; Munnich & Rustin, 2001; Reif, Voos, & Rassow, 2001; Schagger, Cramer, & 
Vonjagow, 1994; Schägger & von Jagow, 1991; Shoffner, 2008).  Additionally, in recent years, 
High Resolution Respirometry has been found to be critical for studying the function of 
oxidative phosphorylation as it provides information about the respiration rate of living cells 
(Sperl et al., 1997).  High Resolution Respirometry is a sensitive electroanalytical method that 
allows oxygen consumption to be measured within living cells and isolated mitochondria 
(Barrientos, 2002; Hutter, Unterluggauer, Garedew, Jansen-Durr, & Gnaiger, 2006; Sperl et al., 
1997).  In this method, specific substrates and inhibitors of respiratory chain enzymes and ATP 
formation are used to evaluate the functions of individual complexes of oxidative 
phosphorylation.   
No one laboratory technique has yet been shown to adequately diagnose MD.  Today, a 
number of tools, such as the Western Blot, Native Gels, and, more recently, High Resolution 
Respirometry, are used simultaneously to reach a final diagnosis of this disease.  Researchers and 
medical professionals continue to improve upon these techniques with the hope of creating a 
more simplified and consistent method of assessing MD.  Because research today places greater 
emphasis on studying the biology and medical presentation of MD, only a handful of clinical 
studies have been conducted investigating the source of cognitive deficits in this disease.  Given 
there are a number of reported cases in which  neuropsychological deficits and psychiatric 
problems were the primary symptoms of MD, there is a clear need to study this field more 
aggressively to capture a fuller clinical profile.  
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Central Nervous System Dysfunction in MD 
Most symptoms of MD are caused by deficient production of ATP in the mitochondria.  
The brain, as an organ that is heavily energy-dependent,  is especially vulnerable to Oxphos 
dysfunction (Finsterer, 2006a).  Moreover, because the brain has a high oxygen requirement, 
lower antioxidant enzymes compared to other organs, and high levels of unsaturated fatty acids, 
it is particularly more vulnerable to the free radicals that are produced by defective mitochondria  
(Nunomura et al., 2006).  A number of neuroimaging studies have been conducted with MD 
patients investigating the impact of mitochondrial dysfunction on the brain; particular brain 
regions are implicated in certain subtypes of MD.   
The most frequent presentation of mitochondrial dysfunction observed in neuroimaging 
studies of infants and young children with Leigh Syndrome (LS), a subtype of MD, is 
degeneration of the brainstem, cerebellum, and basal ganglia (Haas & Dietrich, 2004).  One of 
the earliest case studies reported is that of a 2 year-old girl with brain lesions in the 
hypothalamus and brainstem and spongiform white matter degeneration (Leigh, 1951), who 
presented with central apnea, ptosis, and opthalmoplegia, and ataxia. Currently, the diagnosis of 
Leigh Syndrome requires neurological evidence of bilateral signal hyperintensities in the basal 
ganglia and brainstem (Dimauro et al., 2004).   
Another subtype of MD that has been well-studied through neuroimaging research is 
MELAS.  Stroke-like lesions in the posterior cerebral hemispheres, particularly the occipital 
lobes, are found to be distinctive in this subtype (Dimauro et al., 2004).  For instance, a review of 
imaging studies of MELAS patients using computed tomography (CT) indicates decreased 
attenuation  of one or both occipital lobes and calcification in the basal ganglia (Haas &Dietrich, 
2004).  A case study was described by Haas and Dietrich (2004) of a 19 year old man with 
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MELAS whose Axial CT scan revealed low attenuation in the left occipital lobe, calcification in 
the thalami, caudate, and lentiform nuclei bilaterally, and high signal intensity in the basal 
ganglia and thalamus.  Furthermore, a case report of a 21 year-old woman with MELAS showed 
small necrotic foci in the cerebral cortex, amygdala, hippocampus, and cerebellum, and 
prominent white matter gliosis (Tsuchiya et al., 1999).                
Kearns-Sayre syndrome (KSS), a mitochondrial myopathic disorder, results from 
mutations in mtDNA and is characterized by progressive limitation of eye movement, mild 
skeletal muscle weakness, short stature, heart block, hearing loss, diabetes, as well as mild 
cognitive impairments and infrequent seizures.  Although KSS is categorized mainly as a 
myopathic condition, neuroimaging studies have revealed diffuse signal abnormalities of the 
central white matter and basal ganglia calcification in these patients (Dimauro et al., 2004).  For 
example, in a 9-year-old girl with KSS, Axial Fluid Attenuated Inversion Recovery  (FLAIR) 
images showed high signal intensity in the globus pallidus, dentate nuclei, tectum, and peripheral 
cerebral white matter (Haas & Dietrich, 2004).  Furthermore, Chu and colleagues (1999) 
presented brain MRI findings on four patients with KSS. Two patients were found to have 
normal MRI, whereas the other two patients had high-signal lesions bilaterally in the subcortical 
white matter, thalamus, and brainstem, and atrophy in the cerebellum. 
Although central nervous system involvement is a commonly reported feature of MD, 
only a few studies have attempted to examine neuropsychological features in this population 
group.   Kartsounis and colleagues (1992) were one of the first to study neuropsychological 
features of MD, administering tests of general intellectual ability, memory, language, and 
perception to 36 patients with mitochondrial myopathy and encephalomyopathy.  Patients were 
determined to have encaphalopathic features if abnormalities were detected in EEG or CT scans.    
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Of the 22 patients with encephalomyopathy, 13 patients (59%) displayed mild to severe 
intellectual disability.  Focal deficits were also found in language (50%), memory (64%), and 
perception (55%).  Among the 14 myopathic patients, fewer showed impairment in intellectual 
ability (14%),  language (7%), memory (14%), and perception (14%).     
In a similar study, Turconi and colleagues (1999) found developmental delay in 68% of 
patients (N=16) with mitochondrial encephalomyopathies.  Even the 20% of patients who 
presented with no encephalopathy exhibited mild cognitive delays, including compromised 
visuospatial abilities and short-term memory deficits. Moreover, performance IQ was found to be 
significantly lower than verbal IQ in children with mitochondrial disorders.  No SPECT evidence 
of greater impairment of the right hemisphere, however, emerged as had been expected given the 
observed pattern of non-verbal deficits (Turconi et al., 1999). 
 In a chart review of 42 children with definite (n=37) and suspected (n=42) MD, 
Nissenkorn and colleagues (2000) found that 18 children (43%) had normal intelligence, while 
24 children (57%) had mental retardation or developmental delay at the time of diagnosis.  Over 
the course of the disease, 17 children (40%) had a static course, while others had acute 
intermittent encephalopathy (21%), slowly progressive deterioration (29%), or acute 
deterioration leading to death or vegetative state (10%). 
In addition to the neurocognitive deficits observed in MD populations, psychiatric 
problems have also been commonly reported in MD.  These include depression, hallucinations, 
personality changes, and psychotic episodes (Berio & Piazzi, 2002; Gardner et al., 2003; Kaller 
et al., 2003).  In Chronic Progressive External Ophthalmoplegia (CPEO), bipolar affective 
disorders were observed to occur (Finsterer, 2006b).  Furthermore, a pattern of loss of 
orientation, paranoid-hallucinatory psychosis, social withdrawal, and odd behavior was evident 
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in a case study of a male patient with MELAS (Sartor, Loose, Tucha, Klein, & Lange, 2002).  
Moreover, a growing number of research studies are finding an association between autism 
spectrum disorders (ASD) and disorders of mitochondrial oxidative phosphorylation (Poling, 
Frye, Shoffner, & Zimmerman, 2006; Weissman et al., 2008).   Other deficiencies include 
impaired consciousness, decreased alertness, concentration, orientation, and reasoning.  In 
particular, disturbed consciousness was most frequently found in Leigh syndrome and Kearns-
Sayre syndrome (Berio & Piazzi, 2002; Crimi et al., 2004). 
The wide range of cognitive deficits and psychiatric issues reported in the literature 
mirrors the heterogeneous presentation of medical problems in the MD population.  Although no 
clear pattern of focal cognitive deficits has yet to emerge for MD patients, the studies to date 
seem to indicate that at least half of the patients diagnosed with MD are cognitively impaired and 
that perhaps non-verbal abilities are more heavily impacted than verbal abilities. Although a few 
studies have investigated neuropsychological aspects of MD, no study to date has attempted to 
directly quantify relationships between the biochemical and cognitive aspects of mitochondrial 
dysfunction.                  
Early Metabolic Dysfunction and Subsequent Disruption of Neurodevelopment: 
Implication for deficits in Attention and Processing Speed 
Based on neuroimaging studies, it appears that subcortical and posterior regions of the 
brain, such as the occipital lobe, cerebellum, brainstem, basal ganglia, and white matter, are more 
frequently impacted by Oxphos dysfunction in MD.  This neuroanatomic profile is consistent 
with brain regions that are formed in the early stages of neurodevelopment and during periods of 
high brain metabolic activity. 
11 
 
In the literature of neurodevelopment, it is well supported that subcortical areas mature 
first, followed by posterior cortical areas, and then anterior regions (Anderson, Northam, Hendy, 
& Wrennall, 2001).  Extensive neuroanatomical studies of cortical development in infants also 
suggest an inside-out pattern in the neuroanatomical growth of the cortex, specifically in regards 
to the extent of dendrites, dendritic trees, and myelination.  For instance, initial myelination is 
known to begin at birth in the pons and cerebellar peduncles.  The most rapid changes in white 
matter also occur during the first two years of human life (Johnson, 2004).         
Neuroimaging studies have shown that the typical immature brain has considerably 
higher energy consumption than the adult brain (Skoyles, 2008), particularly in the brainstem, 
cerebellum, and basal ganglia (Chugani, Phelps, & Mazziotta, 1987).   The factors contributing 
to the increased subcortical metabolic activity in infancy to early childhood include a greater 
number of synapses in the immature brain and the inefficiency of their axons prior to full 
myelination.  If brain metabolic activity is impaired, it is expected that it will interfere with the 
proper development of brain regions associated with high energy consumption.  
Metabolism, which refers to the biochemical process of energy use, is impaired with 
dysfunction in the oxidative phosphorylation process.  Brain metabolic abnormalities, as 
measured by decrease in N-acetylaspartate (NAA) and accumulation of lactate, are often 
detected in MD using proton MR spectroscopy (Detre et al., 1991; Mathews et al., 1993).  In a 
study conducted by Bianchi and colleagues (2003), significant reduction in choline and NAA 
was observed when MR spectroscopy was positioned in the axial images of deep cerebellar 
hemisphere, white matter, and the parieto-occipital cortex of either hemispheres of 15 patients 
with MD.  As expected, metabolic dysfunction was detected within the subcortical and posterior 
brain regions, and in the related white matter.      
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Clinical studies have shown that disruption in early neurodevelopment, either caused by 
diffuse disease or brain insults, often lead to cognitive deficits subserved by subcortical brain 
regions, such as processing speed and attention.  For instance, children who have interrupted 
oxygen intake during sleep due to obstructive sleep apnea syndrome demonstrated increased 
compensatory cerebral blood flow and slightly impaired processing speed and visual attention 
(Hill et al., 2006).  Furthermore, such neurobehavioral impairments were frequently reported 
following treatment of childhood cancers with cranial irradiation (CRT). Findings from studies 
of children treated with CRT prior to age five years showed greatest dysfunction in information-
processing speed, a skill associated with subcortical white matter (Anderson, Godber, Anderson, 
Smibert, & Ekert, 1995).  A related study investigated attention and information processing skills 
in children treated with both CRT and chemotherapy.  Anderson and colleagues (2004) found 
that these children showed deficits in processing speed for complex tasks and selective and 
shifting attention compared to same age peers (Anderson, Godber, Smibert, Weiskop, & Ekert, 
2004) .  They suggested that these skills may be impaired due to the vulnerability of cerebral 
white matter in early childhood.   
The development of white matter and gradual myelination and its association with 
increasing processing speed is well-established in the literature of neurodevelopment.  For 
instance, in a longitudinal study by Kail and Ferrer (2007), a sample of children and adolescents 
(N= 503) was tested twice over a span of two years using two psychometric measures of 
processing speed: Visual Matching and Cross-Out.  In another sample, children and adolescents 
(N= 277) were tested four times, every 6 months, on Cross-Out.  They examined age-related 
changes in performance on both tasks and found that processing speed became increasingly 
faster during childhood, but the rate at which the speed increased slowed in adolescence and 
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corresponded with changes in brain size and body mass (Kail & Ferrer, 2007).  Furthermore, the 
role of subcortical brain regions in processing speed has also been demonstrated in a number of 
studies.  For example, O’Brien and colleagues (2002) examined the impact of subcortical grey 
and white matter lesions on cognitive function in a large sample of non-demented elderly adults 
and found that the extent of subcortical lesions in the caudate and thalamus was significantly 
correlated with impaired performance on tests of processing speed.   
Within the complex set of cortical networks that are involved in attentional processes, 
particular subcortical brain regions are known to play a critical role.  The reticular activating 
system (RAS) within the brainstem, for instance, is identified as important for arousal and 
maintaining the alert state in the cerebral cortex.  The RAS also plays a key function in filtering 
out repetitive stimuli and preventing sensory overload (Steriade, 1996).  In a PET study, 
activation of the midbrain reticular formation and thalamic intralaminar nuclei was observed 
when participants went from a relaxed awake state to an attention-demanding reaction-time task, 
confirming the importance of RAS in arousal and vigilance (Kinomura, Larson, Gulyas, & 
Roland, 1996).  Moreover, basal ganglia are implicated in attention and often studied in the 
context of children with ADHD.  For instance, Sobel and colleagues (2010) examined the 
morphologic features of the basal ganglia nuclei in children with ADHD and found significant 
inward deformations in the caudate, putamen, and globus pallidus.  The more prominent inward 
deformations in the nuclei were associated with the severity of ADHD symptoms. 
Neuroimaging studies have shown that the subcortical, posterior, and white matter 
regions of the brain are often impact by mitochondrial dysfunction.  These areas are consistent 
with the brain regions formed in the early stages of neurodevelopment and during periods of high 
brain metabolic activity. Given the neuropsychological sequelae observed in other subcortical 
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and white matter diseases early childhood, it is suggested that children with MD should also 
exhibit deficits in processing speed and attention. 
Summary  
 This study focused on the associations between cognitive functioning and the protein 
chemistry and structural functioning of the oxidative phosphorylation system in the 
mitochondria, primarily the complexes that are involved in the production of ATP.  The main 
goal of this study was to investigate processing speed and attentional correlates of biochemical 
and medical indices in children with MD.  Given that MD is caused by the insufficient 
production of ATP in the Oxphos system, it is possible that data derived using laboratory 
techniques that directly examine the biochemical structure and function of proteins and 
complexes of the mitochondrial membrane relate to cognitive and functional abilities.  
The laboratory tools and medical data that were used in this study to identify 
relationships between medical indices of the disease and cognitive measures were the Western 
Blot, Native Gels, High Resolution Respirometry, and the Nijmegen diagnostic criteria.  The 
findings from these laboratory methods were investigated in relation to measures of processing 
speed and attention based on the prediction that decreased metabolic activity will interfere with 
early neurodevelopment and impact related neuropsychological processes.   
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CHAPTER 2 
METHODS 
 
General Overview 
All participants for this IRB approved study were recruited from Medical Neurogenetics 
(MNG).  Dr. John Shoffner was the primary diagnostician for this sample, a co-investigator on 
this project, and a GSU adjunct faculty member in Biology.  He is Board Certified in Neurology, 
Biochemical Genetics, and Molecular Genetics.  All medical, laboratory, genetic, and related 
information about each patient were made available from MNG upon parental consent. 
For the study, children (ages 4-13) who received a diagnosis of MD from Dr. Shoffner 
were recruited.  If parents agreed to enroll their children in the study, they were invited to come 
in for an evaluation which took place either at 1) the Urban Life Building Psychology Clinic at 
Georgia State University, or at 2) the MNG clinic.  A neurobehavioral assessment was completed 
under Dr. Robin Morris’ supervision.  The assessment consisted of a clinical interview and 
clinical and psychological profile questionnaires with the parents, neuropsychological testing 
with the child, and a feedback session with the parents. The full evaluation took between 3 and 4 
hours, with breaks as needed based on the age and needs of the children to reduce fatigue or 
frustration.  After an evaluation report was completed, parents were invited to come back for a 
feedback session.         
 Procedures 
A recruitment letter and consent form were either mailed or handed to parents of MD 
children meeting the study criteria by the staff at MNG. The criteria for participation in the study 
included: 1) clinical diagnosis of MD, 2) age between 4 to 13 years, 3) English primary 
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language, and 4) laboratory work-up from MNG.  The following exclusionary criteria were used 
to screen subjects recruited from the initial study based on medical history and parent report: 1) 
severe, uncorrected hearing or visual impairment and 2) history of significant head injury. 
Families interested in participating in the study were asked to mail a signed copy of the 
consent form to the MNG clinic.  Once the consent forms were received, the parents were 
contacted by phone to answer questions and schedule the parent interview and child testing 
sessions.  The children were asked to sign the assent form upon arrival for the testing session.  
However, if the child was too cognitively impaired to understand the purpose of the study, only 
the legal guardian’s consent was required.  In all situations, an attempt was made to provide a 
verbal explanation of the research study that was tailored to the participant's level of 
understanding.  For purposes of confidentiality, participant was assigned a unique identifying 
code number for his or her study records which was separated from his or her name or any other 
information that could be identifying.  All records were stored in a locked office in a locked 
cabinet.   
Participants 
A total of 25 children with MD, aged 4 through 13 years, participated in this study. 
Although 38 children were consented into the study, three children were excluded because they 
failed to meet the criteria for the study and six participants were not able to be scheduled for 
participation.  One participant died prior to the scheduled parent interview and testing.  Three 
participants failed to come back for a testing session after parent interviews were completed due 
to scheduling difficulties.   Although all 25 participants had a basic laboratory work-up done at 
MNG as required for participation in this study, only 18 western blots, 11 native gels, 3 
fibroblast high resolution respirometry, and 9 skeletal muscle high resolution respirometry were 
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available for this study due to pending laboratory data analysis or lack of sufficient tissue 
samples obtained.  Participants in this sample were evenly distributed between males and 
females, and had a mean age of 8.8 years at the time of testing.  Of the 25 children, 24 were 
Caucasian and one was Asian.  Demographics of the final sample are described in Table 1. 
Medical and Laboratory Measures  
Medical and laboratory results were made available through the patient database at MNG.  
Only the results from the most recent assessments completed were used for this study.   
Nijmegen Diagnostic Criteria 
The Nijmegen mitochondrial disease criteria form (see Appendix A) was completed for 
all participants based on their medical records.  The diagnostic scores for Clinical, Biochemical, 
and Genetic Criteria were used in the study as overall medical indices of MD.   
Western Blot (Oxidative Phosphorylation Subunit Proteins) 
Skeletal muscle was obtained from subjects’ quadriceps through a muscle biopsy.  The 
testing procedure involved isolating cellular proteins of interest, separating these proteins 
through gel electrophoresis, transferring them to ployvinylidene fluoride membrane, and later 
visualizing them by using antibodies specific to the nuclear DNA and mtDNA that code for 
specific oxidative phosphorylation subunits.  Results of the protein analysis were expressed as 
the percentage of GAPDH, a constitutively expressed protein.  For this study, any of the 5 
subunits was deemed abnormal if the subunit/GAPDH ratio was one standard deviation below 
the mean of the control reference.                  
Blue and Clear Natives Gels 
 In the Blue Native Gel, intact oxidative phosphorylation supercomplexes and monomeric 
oxidative phsophorylation enzymes were separated electrophoretically using a 3%-12% gradient 
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Bis-TRis ployacrylamide gel.  The Blue Native Gel was used to qualitatively assess the 
formation of the Supercomplex (comprised of Complex I, III, and IV) and the monomeric 
oxphos Complexes III through V.  Monomeric oxphos Complexes I and II were assessed with 
the Clear Native Gel.  The presence of abnormalities in these complexes and supercomplex were 
determined clinically by Dr. Shoffner prior to their use in this study.        
High Resolution Respirometry for Fibroblasts 
 Fibroblast respiration was assessed in the presence of physiological substrates.  Five ratio 
measures were developed: the Uncoupling Ratio, defined as Cru / Cr, which expresses the 
respiratory reserve capacity; the Net Routine Flux Control Ratio (Cr/ Cru), which assesses how 
closely routine respiration operates to the respiratory capacity of oxidative phosphorylation; the 
Respiratory Control Ratio (RCR), defined as Cru / Cro, which assesses the uncoupling and oxphos 
dysfunction; the Leak Flux Control Ratio (Cro / Cru ), which serves to measure the inverse of 
RCR and represent proton leak with inhibition of ADP phosphorylation by oligomycin; and 
Phosphorylation Respiratory Control Ratio (RCRp), defined as (Cr-Cro)/Cru (or 1/UCR-1/RCR, 
which expresses phosphorylation-related respiration as a function of respiratory capacity.  All 
these ratios were considered abnormal if values were one standard deviation below or above the 
mean as determined by each ratio’s function.     
High Resolution Respirometry for Skeletal Muscles 
For this procedure, live muscle saponin was permeabilized for analysis.  This protocol 
assessed functioning of intact coupled mitochondria as well as the maximum respiratory capacity 
of the mitochondria in an uncoupled state.  Based on MNG’s method, the analysis of skeletal 
muscle respiration was conducted similarly to the fibroblast’s described above in that it 
evaluated the Uncoupling Ratio, Net Routine Flux Control Ratio, Respiratory Control Ratio, and 
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the Leak Flux Control Ratio.  The fifth ratio that was assessed was oxygen consumption when 
ADP was added to a medium of glutamate and malate as opposed to when it was not.  Lastly, the 
succinate-suplemented media ratio was used to evaluate oxygen consumption with the addition 
of succinate.  Again, abnormal values for these ratios were defined as one standard deviation 
above or below the mean. 
Processing Speed and Attention Measures 
For this study, it was predicted that processing speed and attention would be primarily 
impacted by the biochemical abnormalities in the mitochondria of MD patients, which were 
presumed to have the greatest impact on subcortical and white matter structures in the 
developing brain. The tests and questionnaires in this study were mainly selected for the 
cognitive areas they measure, appropriate age ranges they provide, length of testing, and 
reliability and validity findings. The primary measures were chosen from the following tests. 
Processing Speed 
 Two subtests from the Differential Ability Scales–Second Edition (DAS-II), Speed of 
Information Processing and Rapid Naming, were used for this study.  The Speed of Information 
Processing (SIP) subtest measures speed in performing quantitative comparisons; specifically, in 
each row of items, the child must identify and mark the one circle that has the greatest number of 
squares.  The number of squares within each circle never exceeds four.  The basic task of SIP is 
relatively easy, and almost all children can solve the items correctly.  The variation in 
performance lies in the time the child takes to complete the task (Elliot, 2007).  Several studies 
support the interpretation of the SIP subtest as a measure of general cognitive speed, including a 
study conducted by Buckhalt and Jensen (1989) using a range of reaction-time measures.  In 
addition, the Rapid Naming (RN) subtest measures speed of lexical access and retrieval.  There 
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are three items within this subtest; in all items, the child names array of colors or pictures as 
quickly as possible without making mistakes.  This test was developed based on the concept of 
rapid automatized naming (Elliot, 2007).  The SIP and RN measures correlate more highly with 
each other than with any other subtests in the DAS-II.    
The DAS-II consists of two age-based versions: the Early Years (ages 2:6-8:11) and 
School Age (5:0 to 16:11).  All participants, excluding one 4- year-9-month old, were given the 
School Age version of the test for consistency.  The results from the 4 year old participant were 
not included as part of the research data.  The normative sample for the DAS-II includes 3,475 
children and adolescents who are representative of the US population census for race, gender, 
community size, and parent education. The reliability coefficient is high ( .95) for the School 
Age level on the DAS-II.  Test-retest reliability scores are very stable for the General Conceptual 
Ability score and cluster scores, ranging from .79 to .94.  Correlations with the McCarthy Scales 
of Children’s Ability (MSCA) are the highest for the Verbal, Perceptual-Performance, or 
Qualitative scales.  For the school age level, all of the DAS composites correlated highly with the 
WISC-R Full Scale IQ, Verbal IQ for 8 to 10 year olds, and Verbal IQ for 14 to 15 year olds. 
Attention  
The Auditory Attention and Response Set subtest of the NEPSY-II was administered to 
measure attention.  This subtest has two parts; Auditory Attention is designed to assess selective 
auditory attention and the ability to sustain it (vigilance), whereas Response Set is designed to 
assess the ability to shift and maintain a new and complex set involving both inhibition of 
previously learned responses and correctly responding to matching or contrasting stimuli.  Only 
the Auditory Attention component of the test was utilized to measure attention.     
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The NEPSY-II is a test designed to assess neuropsychological development in children 
ages 3-16.  The 4-year-old participant was also administered the same tests using 5-year-old 
norms; again, the results were excluded from the research data.  The NEPSY-II normative data 
were collected from 2005 to 2006 using a sample that was stratified on key demographic 
variables (i.e., age, sex, race/ethnicity, parent education level, and geographic region) according 
to the October 2003 U.S. census data.   
In general, the various reliability measures indicate adequate to good reliability for the 
different types of scores in NEPSY-II (Korkman & Kemp, 2007). The mean reliability across the 
age groups for most subtests is between .70 and .90.  The test-retest correlations of the different 
age groups vary between .55 and .81. In addition, correlations between the NEPSY-II and D-
KEFS subtests assessing similar processes provide support for the convergent validity of the 
NEPSY-II.  The attention measure of NEPSY-II also correlates with the inattention error score (-
.76), visual attention subtest (-.40), and statue subtest (-.59) of the Auditory Continuous 
Performance Test.    
Attention was also assessed using the parent rating of Attention Problems from the 
Behavior Assessment System for Children 2nd Edition (BASC-II).  The BASC-II is a diagnostic 
tool designed to evaluate the behavior of children and young adults, ages two to 25 years 
(Reynolds & Kamphaus, 2004), based on diagnostic criteria from the DSM-IV and DSM-IV-TR, 
as well as other behavioral instruments.  The BASC-II is a multi-method tool, since it measures 
numerous behavioral and personality characteristics. 
The BASC-II was normed using two populations: 1) a general population sample of 
American children and adolescents from various settings, and 2) a clinical norm sample of 
American children and adolescents (ages 4-18) who were diagnosed with emotional, behavioral, 
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or physical problems.  The general population sample had a total of 4,800 Parent Rating Scales 
(PRS) reports.  In terms of age groups, there were 2,250 pre-schoolers aged 2-5 years, 3,600 
children aged 6-11, and 5,500 adolescents (ages 12-18).  In terms of gender and ethnic 
representation, the general sample was very close to U.S. population estimates.  The clinical 
sample had a total of 5,281 reports across the TRS, PRS and SRP scales. The sample comprised 
317 pre-school aged (2-5) children, 673 children ages 6-11, and 789 adolescents ages 12-18. The 
children in this sample had a variety of diagnoses, including specific learning disabilities, 
speech/language impairments, emotional and behavioral disturbances, hearing impairment and 
ADD/ADHD. 
An analysis of internal consistency yields coefficient alpha reliabilities generally in the 
.90s for the composite scales, and reliabilities generally in the .80s for individual scales across all 
forms for both the general sample and the clinical sample (Reynolds & Kamphaus, 2004).  When 
samples of individuals distributed across the three age groups were retested with the BASC-II 
one to eight weeks after the first administration, the test-retest reliabilities resulted in average 
correlations in .80s for composite scores and between the .70s and .80s for individual scales 
across all age groups. For validity measures, the parent rating scale was compared with other 
behavioral measures such as the ASEBA Child Behavior Checklist for Ages 1-5, the Conners’ 
Parent Rating Scale-Revised, the Behavior Rating Inventory of Executive Functioning (BRIEF), 
and the BASC-I.  Generally, the BASC-II correlated in the .70s and .80s with the first three 
scales, and in the .90s with the previous BASC-I. 
Supplementary Cognitive Measures 
In addition to the primary processing speed and attention measures that were collected, 
this study also conducted a more thorough clinical evaluation to ensure that other variables 
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would be available to contextualize the results.  Appendix C provides a list of all the tests that 
were administered.  The tests were administered in the same order for each participant. 
Verbal Functioning 
 The Verbal Cluster of the DAS-II was administered; this cluster comprises the Word 
Definition and Verbal Similarities subtests.  The Word Definition subtest measures the ability of 
the child to define words presented orally by the examiner.  As well as requiring access to a 
previously acquired store of words together with their meanings, Word Definition measures 
expressive language ability.  The Verbal Similarities subtest assesses the ability of the child to 
identify the common concept linking three words.  This subtest is a measure of a verbal 
development and verbal reasoning (Elliot, 2007).     
The Word Generation subtest from the NEPSY-II was also administered.  This subtest is 
designed to assess verbal productivity through the ability to generate words within semantic and 
initial letter categories (Korkman & Kemp, 2007).  The child is given a semantic or initial letter 
category and asked to produce as many words as possible in 60 seconds. 
Visual-Spatial-Perceptual-Motor Functioning: 
 Two subtests from the DAS-II were administered to measure perceptual reasoning: 
Sequential and Quantitative Reasoning (SQR) and Pattern Construction (PC).  The SQR subtest 
measures the ability to perceive sequential patterns in geometric figures or common rules in 
numerical relationships.  The problems in this subtest are presented visually, with little verbal 
instruction.  Moreover, the PC subtest assesses spatial ability in children by requiring them to 
copy patterns with wooden blocks, foam squares, and blocks with different patterned and colored 
sides (Elliot, 2007).  The Arrows subtest from the NEPSY-II was also administered to assess 
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ability to judge line orientation.  On this task, the participant was required to look an array of 
arrows arranged around a target and indicates the arrow that points to the center of the target. 
Two sensorimotor tasks were administered from the NEPSY-II: Fingertip Tapping and 
Imitating Hand Position.  Fingertip Tapping has two parts: the first part is designed to assess the 
child’s finger dexterity and motor speed, whereas the second part is used to assess rapid motor 
programming.  The participant was asked to copy a series of finger motions demonstrated by the 
examiner as quickly as possible.  Imitating Hand Position is designed to assess the ability to 
imitate hand and finger positions.  On this task, the participant was required imitate various hand 
positions demonstrated by the examiner (Korkman & Kemp, 2007).          
Memory Functioning 
 Two measures from the DAS-II, Recall of Digits Backward (RDB) and Recall of 
Sequential Order (RSO), were administered to measure working memory: the ability to process 
information that is being held in verbal short-term memory.  On the RDB subtest, participants 
were asked to recall in reverse order a list of numbers presented orally by the examiner.  In 
contrast to forward-digit recall tasks (a basic short-term memory process), reverse-digit recall 
requires deeper processing of the stimulus because the child must be able to both remember and 
manipulate the information (Elliot, 2007).  On the RSO subtest, participants were required to re-
sequence an orally-presented list of body parts, arranging the parts from highest to lowest.  The 
early, easier items were done with the aid of a drawing of a human figure, then the picture was 
removed, requiring the more difficult items to be performed using mental representation alone. 
 Two memory and learning tasks were also selected from the NEPSY-II: List Memory and 
Memory for Faces.  List Memory was administered to assess verbal learning and memory, rate of 
learning, and the role of interference in recall for verbal material.  On this task, participants were 
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required to read a list of words several times, recalling them after each presentation.  A delayed 
task assessed long-term memory for words.  In addition, the Memory for Faces subtest was 
administered to assess encoding of facial features, as well as face discrimination and recognition. 
On this task, participants looked at a series of faces; they were then shown three photographs at a 
time from which they were required to select a face they had previously seen.  Again, a delayed 
task was given to assess long-term memory for faces.                
Executive Functioning 
 Three subtests were administered to assess executive functioning:  NEPSY Auditory 
Attention Response Set, Design Fluency, and Inhibition.  The Response Set component of the 
Auditory Attention subtest is designed to assess the ability to shift and maintain a complex set 
involving both inhibition of previously learned responses and the ability to correctly respond to 
matching or contrasting stimuli.  Design fluency is a task designed to assess the behavioral 
productivity in the ability to generate unique designs by connecting up to five dots, presented in 
two arrays: structured and random.  The participants were required to draw as many designs as 
they could on each array within a specified time limit.  Lastly, the Inhibition subtest was 
administered to assess the ability to inhibit automatic responses in favor of novel response and 
the ability to switch between response types.  On this task, participants looked at a series of black 
and white shapes or arrows and named either the shape or direction or an alternate response, 
depending on the color of the shape or arrow.   
Social Perception 
 This subtest is designed to assess the ability to recognize affect (happy, sad, anger, fear, 
disgust, and neutral) from photographs of children’s faces in four different tasks.  On one task, 
the participants are simply required to state whether or not two photographs depict faces with the 
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same affect.  On a second task, he or she selects two photographs of faces with the same affect 
from three to four photographs.  On a third task, the child selects one of the four faces that depict 
the same affect as a face at the top of the page.  Finally, the child is briefly shown a face, and 
from memory, selects two photographs that depict the same affect as the face previously shown 
(Korkman & Kemp, 2007).   
Behavioral and Adaptive Functioning 
Parents were also asked to rate their children’s behavioral and adaptive functioning 
using the BASC-II and the Vineland Adaptive Behavior Scales-II.  In addition to Attention 
Problems, other areas rated on the BASC-II include Externalizing Problems (Hyperactivity, 
Aggression, and Conduct Problems), Internalizing Problems (Anxiety, Depression, and 
Somatization), Atypicality, and Withdrawal.  Adaptive Skills are also rated in areas of 
Adaptability, Social Skills, Leadership, Activities of Daily Living, and Functional 
Communication.   
The Vineland-II Parent/Caregiver version of the structured interview was also 
conducted with the parents. This measure took between 30 minutes to an hour to complete.  This 
structured interview was designed to measure four domains of adaptive behavior: 
Communication, Daily Living Skills, Socialization, Motor Skills.  Maladaptive behavior 
(Internalizing and Externalizing Problems) was also assessed.  Standardization sampling for the 
Vineland-II follows the 1980 census data and includes 3,000 subjects from birth through 18 
years and 11 months equally divided by sex (Sparrow, Cicchetti, & Balla, 2005).                                                                                         
In terms of reliability, split-half and test-retest reliability coefficients for the Composite 
scores are good, ranging from median values of .83 for the Motor Skills domain to .94 for the 
Composite.  Inter-rater coefficients, however, are somewhat lower for the same measures (.62 to 
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.78).  Selected standardization subgroups were compared with the original Vineland, K-ABC, 
and PPVT-R to measure validity.  These measures exhibited low to moderate correlations, with 
generally higher coefficients when the comparisons were made on subjects with handicapping 
conditions. 
Academic Achievement 
Wechsler Individual Achievement Test-Second Edition (WIAT-II) was used to screen the 
participants’ level of academic achievement (PsychCorp, 2005).  Only two subtests from the 
WIAT-II were administered for the purposes of this study: Word Reading and Numerical 
Operations.   
 The WIAT was standardized on 5,586 individuals with two standardization samples 
drawn for PreK-12 (ages 4-19) and for the college-adult population. Both standardization 
samples were stratified on the basis of grade, age, sex, race-ethnicity, geographic region, and 
parent education level, based on the data from the 1998 Bureau of the Census.  Internal 
consistency reliability estimates of the WIAT-II subtests are very high for Word Reading (.97) 
and Numerical Operations (.91).  In the school-aged sample, test-retest correlations for the 
subtests are consistently above .85 and test-retest correlations for the Composite scores were 
above .90.  In terms of validity, the corresponding subtests of the WIAT and the WIAT-II were 
strongly correlated (above .80) in the school-aged sample for those subtests with minimal content 
changes. 
Data Analysis 
Preliminary analyses were conducted to ensure no violation of the assumption of 
normality, linearity, multicollinearity, homoscedasticity, and independence of residuals.  The 
Kolmogorov-Smirnov test of normality was run for all variables to determine normal 
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distribution.  For normally-distributed continuous variables, two-tailed Pearson’s correlations 
and independent sample t-tests were conducted.  Spearman’s two-tailed correlations were 
performed for variables with non-normal distributions. Except for the subdomains of the 
Vineland that were analyzed using the Vineland-scaled score, all other t-scores, scaled scores, 
and standard score were converted to z-scores so that most of the data would be on the same 
quantitative scale to facilitate interpretation of the results. 
The primary hypotheses of this study explored associations among processing speed, 
attention, biochemical abnormalities, and medical indices using multiple regression analysis, 
independent sample t-tests, and correlations.  Separate regression analyses using measures of 
processing speed and attention were conducted to predict the total number of abnormalities 
detected through the western blot, native gels, and high resolution respirometry techniques, as 
well as the Nijmegen clinical and biochemical indices.  The DAS-II Processing Speed Cluster, 
which is a composite score for DAS-II Speed of Information Processing and DAS-II Rapid 
Naming, was consistently used as a predictor variable in the regression analyses.  The BASC-II 
Attention Problems and NEPSY-II Auditory Attention Total Correct were used in separate 
regression analyses as a predictor variable in conjunction with the DAS-II Processing Speed 
Cluster.  Collinearity diagnostics (Tolerance and Variance Inflation Factor) between the 
predictor variables were found to be within acceptable ranges suggesting no multicollinearity.       
In addition to the primary measures, correlation analyses and t-tests were performed 
across select cognitive measures and all standardized biochemical measures to evaluate the 
potential for other associations outside of the study’s primary hypotheses.  As in the tests of the 
primary hypotheses, participants were assigned to an abnormal group (normal vs. abnormal) if 
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their biochemical z-scores were below or equal to -1.  Pearson’s correlation was performed on 
variables that were normally distributed.  Otherwise, Spearman’s correlation was performed.  
On the Nijmegen, the relationships across the main criteria domains (Total Clinical and 
Total Biochemical), Clinical subdomains (Neuromuscular Manifestations, Central Nervous 
System and other Organ Involvement, Metabolic and Imaging studies, and Tissue Morphology), 
and all standardized cognitive measures were investigated through correlation analyses.  T-tests 
were performed to evaluate relationships between the overall clinical, biochemical, and genetic 
criteria and all cognitive measures.  Two groups (“Highly Probable/Probable” and 
“Possible/Unlikely”) were formed for both the Clinical and Biochemical criteria. 
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Table 1 Demographic Information (N=25)  
      
           % (n)    
 
    
Sex 
     Female      48 (12) 
     Male      52 (13) 
 
Race 
     Caucasian           96 (24) 
     Asian           4   (1) 
        
Handedness 
     Right      68 (17)   
     Left       20 (5) 
     Unknown      12 (3)     
 
Years of Education 
     None      4   (1)    
     Pre-kindergarten     12 (3) 
     Kindergarten     16 (4) 
     1st grade      0   (0) 
     2nd grade      20 (5) 
     3rd grade      16 (4) 
     4th grade      16 (4) 
     5th grade      4   (1) 
     6th grade      8   (2) 
     7th grade       4   (1) 
________________________________________________________________________  
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CHAPTER 3 
SAMPLE DESCRIPTION 
 
 Given the uniqueness of this sample and the complex nature of their clinical profile, a 
description of the participants’ general medical history, laboratory results, and cognitive 
functioning is provided.     
Medical Review and History 
Medical records and parent interviews revealed a history of developmental, behavioral, 
and psychological problems in a number of participants.  Problems during pregnancy and 
delivery were reported in 40% (n=10) and 44% (n=11) of the participants, respectively.  
Developmental delays were reported in 72% (n=18) of the participants.  Previous and concurrent 
diagnoses include bipolar disorder (8%, n=2), anxiety (16%, n=4), attentional disorders (12%, 
n=3), communication disorder (4%, n=1), learning disorder (8%, n=2), autism/aspergers (28%, 
n=7), obsessive compulsive disorder (12%, n=3), cerebral palsy (8%, n=2), Rett syndrome (4%, 
n=1), and Gerstmann syndrome (4%, n=1).  History of seizures was reported in 32% (n=8) of the 
participants.  Frequently reported medical concerns include fatigue (76%, n=19), motor/muscle 
problems (76%, n=19), gastrointestinal and eating problems (40%, n=10), and sensitivity to heat 
and cold (36%, n=9).   
Complex Abnormalities: Western Blot and Native Gels 
The most commonly diagnosed complex type among the participants was Complex I 
(68%), followed by Complexes III (36%) and V (20%) as shown in Table 2.  This data includes 
complexes that are part of multicomplex (combination type) diagnoses.  Notably, none of the 
participants were formally diagnosed with Complex II defect, even though abnormal Complex II 
proteins were detected through the Western Blot in 8 participants as shown in Table 3.  This may 
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be because Complex II abnormalities were not confirmed with the native gels (Table 4).  
Consistent with diagnoses given to participants, the most commonly detected protein 
abnormalities on the Western Blot were from Complex I and III, which were present in 60% of 
the participants for both complex types.  The Complex I abnormalities were also the most 
frequently identified (63.6%) on the Native Gels.  In contrast, only 9.1% of the participants were 
assessed to have abnormal Type III complexes using this method.  On the Western Blot, protein 
abnormalities related to Complexes IV and V were detected in 20% and 4% of the participants, 
respectively.  Moreover, abnormalities in Complexes IV and V were identified in only 9.1% of 
the participants using the Native Gels.  
Oxygen Consumption: High Resolution Respirometry  
  High Resolution Respirometry results were collected from 10 participants to measure 
oxygen consumption within the living cells.  Descriptive statistics are provided in Table 5.  
When findings from skeletal muscles (n=9) and fibroblasts (n=3) were combined, abnormal 
Uncoupling and Net Routine Flux Control ratios were found in 60% of the participants, whereas  
abnormal Respiratory Control and Leak Flux Control ratios were found in only 20%.  In 
addition, 66.7% of participants presented with abnormal ratios of oxygen consumption in the 
skeletal muscle cells when ADP was added to a glutamate and malate medium and when 
medium was supplemented with succinate. 
Nijmegen Diagnostic Criteria 
 Among the three Nijmegen criteria scores, the Biochemical Criteria was found to be most 
affected with 60.9% of the participants receiving either a Highly Probable or Probable score. 
Genetic mutations were identified in less than half of the participants (45%).  Notably, only 32% 
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of the participants met clinical criteria for Highly Probable or Probable mitochondrial disease.  
Table 6 summarizes the findings.        
Cognitive Measures 
On average, participants performed at least 1 standard deviation below the expected mean 
across all cognitive subtests, excluding NEPSY-II Word Generation-Semantic, NEPSY-II 
Memory for Faces Delayed, and WIAT-II Word Reading.  The mean scores on the selected 
cognitive measures ranged from borderline (z-scores from -2.00 to -1.40) to low average (z-
scores from -1.39 to -.75).  Descriptive summary of performance on the cognitive measures are 
provided in Table 7.    
Verbal Skills 
The DAS-II Word Definition, DAS-II Verbal Similarities, and NEPSY-II Word 
Generation subtests were used to measure verbal abilities.  The participants’ overall performance 
on the DAS-II Verbal Cluster score was low average with a mean z-score of -1.26.  On both of 
the individual verbal subtests, 45.5% of the participants performed 1 SD below the expected 
mean, receiving an average z-score of -1.15 and -1.02 on the Word Definition and Verbal 
Similarities subtests, respectively.  The participants’ performance on the Word Generation 
subtest was notable for poorer ability to generate words using initial letter prompts compared to 
semantic categories in relation to same-aged peers.  Specifically, 72.2% of the participants 
performed 1SD below the expected mean on initial letter prompts compared to 47.8% on 
semantic categories.    
Visual-Spatial-Perceptual-Motor Functioning: 
On average, the participants demonstrated low average ability to perceive sequential 
patterns in geometric figures or common rules in numerical relationships as measured by the 
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Sequential Quantitative Reasoning subtest on the DAS-II.  The participants also demonstrated 
low average ability to judge line orientation as measured by NEPSY-II Arrows.  Greater 
difficulty was observed, however, on the Fingertip Tapping and Imitating Hand Position 
subtests, with a mean performance in the borderline range on these sensorimotor tasks.  
Consistently, a lower performance was observed in the borderline range on a perceptual 
reasoning task with a motor component (DAS-II Pattern Construction), again suggesting greater 
weakness in fine motor skills.  
Memory and Learning 
Two measures from the DAS-II, Recall of Digits Backward (RDB) and Recall of 
Sequential Order (RSO), were administered to measure working memory.  The participants’ 
performance on the Working Memory cluster was in the borderline range.   The average 
performance on the individual working memory subtests, Recall of Digits Backward and Recall 
of Sequential Order, were in the borderline and low average ranges, respectively.  In terms of 
rote memory for both immediate and delayed verbal information (NEPSY-II List Memory and 
List Memory Delayed Total Score), the average participant performed in the low average range 
with a mean z-score of -1.14.  Similarly, on the NEPSY-II Memory for Faces, participants 
displayed low average ability for both immediate and delayed recall of faces. 
Processing Speed 
 Two measures, Speed of Information Processing and Rapid Naming from the DAS-II, 
were administered to measure Processing Speed.  Overall, participants performed in the 
borderline range on the Processing Speed Cluster, as well as on the individual scores.  However, 
more participants received lower scores on the task measuring the speed of performing 
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quantitative comparisons (Speed of Information Processing) compared to the task measuring 
speed of lexical access and retrieval (Rapid Naming). 
Attention 
 The NEPSY-II Auditory Attention subtest was administered to assess selective and 
sustained auditory attention.   The mean z-score on this task was -1.13, which is in the low 
average range. The participants’ parents were also asked to rate their children’s level of attention 
problems on the BASC-II.  On this measure, participants were slightly elevated, with a mean z-
score of -1.13 as shown in Table 8.      
 Executive Functioning 
 Three subtests were administered to assess executive functioning:  NEPSY-II Auditory 
Attention Response Set, Design Fluency, and Inhibition.  On average, the participants performed 
in the borderline range across these tasks.  For instance, the participants received a mean z-score 
of -1.57 on the NEPSY-II Response Set, a task that measures the ability to shift and maintain a 
new and complex, inhibit previously learned responses, and correctly respond to matching or 
contrasting stimuli.  The participants also demonstrated difficulty on the NEPSY-II Inhibition 
subtest, a task assessing the ability to inhibit automatic response in favor of novel responses.  
Lastly, the average NEPSY-II Design fluency z-score was also in the borderline range, which 
shows that participants had problems with behavioral productivity.  
Social Perception 
 The NEPSY-II Affect Recognition subtest was administered to assess the ability to 
recognize emotions (happy, sad, anger, fear, disgust, and neutral) in people’s faces.  The 
participants performed on the low average range on this task.    
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Academic Achievement 
Two subtests from the WIAT-II were administered: Word Reading and Numerical 
Operations.  On average, the participants demonstrated low average skill in basic reading and 
math.  
Behavior and Adaptive Functioning 
On average, participants were rated by their parents as elevated on the Somatization scale 
on the BASC-II.  The overall high rating on Somatization, however, was not surprising given the 
many symptoms that these children experienced were due to their medical condition.  For 
example, parents were likely to endorse that their child “complains of pain”, “has stomach 
problems”, “gets sick”, “vomits”, et cetera, all of which are common symptoms of MD.  
Atypicality ratings were also elevated, on average, indicating a higher level of unusual thoughts 
and behaviors or disconnection from one’s surroundings.  Parents endorsed items indicating that 
participants do “do strange things”, “say things that make no sense”, “babble”, or “act confused”.  
According to Reynolds and Kamphaus (2004), a high Atypicality score may be an indicator of 
psychotic tendencies, immaturity or developmental delay, mental retardation, or autism spectrum 
disorders.  This is consistent with previous research (Finsterer, 2007) and clinical reports of 
children, many of whom are developmentally delayed and have cognitive deficits.     
Consistently, participants were also rated significantly low across most Adaptive indices 
on the BASC-II and Vineland-II.  For instance, on average, participants were rated low on their 
overall adaptive skills/behavior index, communication, and daily living skills on both the BASC-
II and Vineland-II.  Additionally, participants were rated low in Socialization and Motor Skills 
on the Vineland-II.   
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Table 2 Clinical Characteristics 
      
     n  M  SD  Range  
    
 
Age at Neuropsychologicala   25  8.75  2.35         5-13 
Assessment 
 
Age at Diagnosisa   25  5.36  3.20        0-11 
 
Time since Diagnosisa  25  3.00  2.43     0-10 
 
     
 
       % (n) 
 
Abnormal Enzyme Complexesb    
     I       68 (17) 
     II         0 (0) 
     III       36 (9) 
     IV         8 (2) 
     V       20 (5) 
 
aReported in years .  bIncludes combination types
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Table 3 Descriptive Statistics of Western Blot 
         
                    
             
Variables                           z-score  Normal Abnormal     
 N M SD Range  % (n) % (n)     
                
            
Complex I (ND6) 15    -.68 1.36 -2.07-3.18  40 (6) 60 (9)     
Complex II (30KDa) 15     .37 1.54 -1.72-2.98  47 (7) 53 (8)     
Complex III (Core 2) 15  -1.35 1.30 -3.30-1.58  40 (6) 60 (9)     
Complex IV (COX II) 15    -.98 0.68 -2.00-  .27  80 (12) 20 (3)     
Complex V (F1 Alpha) 15  -1.15 1.41 -2.95-1.17  53 (8)   4 (7)     
            
Total Abnormalitiesa (Max=5) 15   2.40 1.96    .00-5.00        
            
Note.  All scores reported in Z-scores except for total abnormalities 
aBased on -scores < -1 
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Table 4 Descriptive Statistics of Native Gels 
   
        
Variables N Normal Abnormal 
  % (n) % (n) 
        
    
Clear Native Complex I  11   36.4 (4)  63.6 (7) 
Clear Native Complex II 11 100.0 (11)    0    (0) 
Blue Native Complex III 11   90.9 (10)    9.1 (1) 
Blue Native Complex IV 11   90.9 (10)    9.1 (1) 
Blue Native Complex V 11   90.9 (10)    9.1 (1) 
Blue Native Supercomplex (I, III, IV) 11   72.3 (8)  27.3 (3) 
       
     
 M SD Range 
        
    
Natives Total Abnormalities (Max=6) 1.18 1.47 0-5 
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Table 5 Descriptive Statistics of High Resolution Respirometry 
 
       
                    
                  z-scores                Assessment  
Variables N M SD Range  N Normal Abnormal  
       %(n) %(n)  
                    
SKELETAL MUSCLES          
Uncoupling 9 -.78 1.43 -2.29-1.56  9 44.4 (4) 55.6 (5)  
Net Routine Flux Control 9 1.47 2.12 -1.14-4.34  9 44.4 (4) 55.6 (5)  
Respiratory Control 9 -.37 1.30 -2.99-1.45  9 77.8 (7) 22.2 (2)  
Leak Flux Control 9  .74 2.29 -1.29-6.38  9 77.8 (7) 22.2 (2)  
Glutamate+Malate+ADP  9 1.86 1.59 .00-5.21  9 33.3 (3) 66.7 (6)  
Succinate Supplemented 9 1.68 1.13 .28-3.53  9 33.3 (3) 66.7 (6)  
          
COMBINED*          
Uncoupling      10 40 (4) 60 (6)  
Net Routine Flux Control      10 40 (4) 60 (6)  
Respiratory Control      10 80 (8) 20 (2)  
Leak Flux Control      10 80 (8) 20 (2)  
                   
 N M SD Range      
                   
Total Abnormalitya 
(Max=4) 10 1.8 1.75  0-4      
                   
Note.  All scores reported in z-scores except for total abnormalities.   
*Combined results from skeletal muscles and fibroblasts 
aBased on z-scores below or above 1 SD. 
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Table 6 Descriptive Statistics of Nijmegen Criteria 
            
                                          Scoring Evaluation   
Variables n Highly Probable Probable Possible Unlikely 
  % (n) % (n) % (n) % (n) 
            
      
CLINICAL CRITERIAa 25 4 (1)      28 (7) 56 (14) 12 (3) 
      
BIOCHEMICAL CRITERIAb 23      43.48 (10) 17.39 (4)   39.13 (9) 0 (0) 
         
         
 M SD Range Normal Abnormal 
    % (n) % (n) 
            
CLINICAL CRITERIAc 2.74   .75 1.00-4.00   68 (17)   32 (8) 
Neuromuscular 
Manifestations (max=2)   .96   .88   .00-2.00   
CNS and other Organ 
Involvement (max=2) 1.48   .67   .00-2.00   
Metabolic and Imaging 
Studies (max=4) 1.35 1.37   .00-4.00   
Tissue Morphology (max=4)   .13   .46   .00-2.00   
BIOCHEMICAL CRITERIAc 1.96   .93  1.00-3.00  39.13 (9) 60.87 (14) 
GENETIC CRITERIA (n=20)     55 (11)   45(9) 
            
Note. aHighly Probable (8-12 pts), Probable (5-7 pts), Possible (2-4 pts), Unlikely (1pt)  
bHighly Probable (>2 tests abnormal), Probable (2 tests abnormal), Possible (1 test abnormal), Unlikely (all normal) 
cNormal=Unlikely or Possible;  Abnormal=Probable or Highly 
Probable    
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Table 7 Descriptive Statistics of Cognitive Variables 
         
  
       
Variables N M SD Range < -1 SD >  -1 SD 
     % (n) % (n) 
       
PROCESSING SPEED (DAS-II)       
Processing Speed Cluster 22 -1.73 1.76 -4.40-1.73 68.2 (15) 31.8 (7) 
Speed of Information Processing 22 -1.51 1.52 -3.70-2.00 72.7(16) 27.3 (6) 
Rapid Naming   22 -1.30 1.53 -4.00-1.00 54.5 (12) 45.5 (10) 
       
ATTENTION (NEPSY-II)       
Auditory Attention Total Correct 21 -1.13 1.54 -3.00-1.00 57.1(12) 42.9 (9) 
       
VERBAL COMPREHENSION (DAS-II)       
Verbal Cluster 23 -1.26 2.12 -4.60-2.47 47.8 (11) 52.2 (12) 
Word Definition 22 -1.15 2.03 -4.00-2.00 45.5(10) 54.5 (12) 
Verbal Similarities 22 -1.02 1.90 -4.00-2.40 45.5(10) 54.5 (12) 
       
WORD RETRIEVAL (NEPSY-II)       
Word Generation-semantic 23   -.91 1.62 -3.00-3.00 47.8 (11) 52.2 (12) 
Word Generation-Initial Letter 18 -1.32 1.44 -2.67-3.00 72.2 (13) 27.8 (5) 
       
PERCEPTUAL REASONING (DAS-II)       
Sequential Quantitative Reasoning  22 -1.16 1.53 -3.60-2.20 50.0 (11) 50.0 (11) 
Pattern Construction 22 -1.46 1.66 -4.00-1.20 68.2 (15) 31.8 (7) 
       
VISUAL & SENSORIMOTOR (NEPSY-II)       
Arrows 22 -1.23 1.55 -3.00-1.33 59.1 (13) 40.9 (9) 
FTT-Dominant Hand Combined z score 20 -1.63 1.41 -3.00-  .67 70.0 (14) 30.0 (6) 
FTT-Nondominant Hand Combined z score 20 -1.75 1.52 -3.00-1.33 70.0 (14) 30.0 (6) 
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FTT-Repetition Combined z score 22 -1.56 1.57 -3.00-1.33 63.6 (14) 36.4 (8) 
FTT-Sequences Combined z score 20 -1.35 1.47 -3.00-1.33 60.0 (12) 40.0 (8) 
Imitating Hand Position Total z score 22 -1.53 1.36 -3.00-1.00 68.2 (15) 31.8 (7) 
       
WORKING MEMORY (DAS-II)       
Working Memory Cluster 22 -1.43 1.80 -4.47-1.07 59.1 (13) 40.9 (9) 
Recall of Sequential Order  22 -1.40 1.76 -4.00-1.40 50.0 (11) 50.0 (11) 
Recall of Digits Backwards 22 -1.20 1.59 -4.00-  .70 40.9 (9) 59.1 (13) 
       
MEMORY (NEPSY-II)       
List Memory  17 -1.14 1.59 -3.67-1.67 52.9 (9) 47.1 (8) 
Memory for Faces   22 -1.09 1.49 -3.00-1.67 50.0 (11) 50.0 (11) 
Memory for Faces Delayed 22   -.80 1.56 -3.00-1.67 50.0 (11) 50.0 (11) 
       
EXECUTIVE FUNCTIONS (NEPSY-II)       
Response Set Total Correct 17 -1.57 1.63 -3.00-1.67 50.8 (10) 41.2 (7) 
Inhibition Naming Combined 22 -1.47 1.60 -3.00-1.33 63.6 (14)  36.4 (8) 
Inhibition Naming Completion Time  22 -1.70 1.54 -3.00-1.00 68.2 (15) 31.8 (7) 
Inhibition Inhibition Combined  22 -1.73 1.38 -3.00-  .67 68.2 (15) 31.8 (7) 
Inhibition Inhibition Completion Time 22 -1.70 1.43 -3.00-1.33 68.2 (15) 31.8 (7) 
Inhibition Switching Combined  19 -1.56 1.56 -3.00-1.33 63.2 (12) 36.8 (7) 
Inhibition Switching Completion Time 19 -1.65 1.76 -3.00-2.67 68.4 (13) 31.6 (6) 
Design Fluency 20 -1.48 1.31 -3.00-  .33 60.0 (12) 40.0 (8) 
       
SOCIAL PERCEPTION (NEPSY-II)       
Affect Recognition  23 -1.00 1.43 -3.00-1.33 52.2 (12) 47.8 (11) 
       
ACADEMIC ACHIEVEMENT       
Word Reading 22   -.83 1.82 -4.00-1.93 40.9 (9) 59.1 (13) 
Numerical Operations 22 -1.15 1.97 -4.00-2.93 54.5 (12) 45.5 (10) 
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Table 8 Descriptive Statistics of BASC-II 
 
          
Variables n   M SD Range 
          
BEHAVIORAL SYMPTOMS INDEX 20   .73   .87  -.40- 2.60 
     
EXTERNALIZING PROBLEMS 20   .13   .97 -1.60-2.30 
Hyperactivity 20   .54 1.21 -1.60-3.40 
 Aggression 20   .16   .75 -1.40-1.00 
Conduct Problems 17 -.16   .88 -1.30-2.00 
     
INTERNALIZING PROBLEMS 20   .89 1.19 -1.30-2.50 
Anxiety 20   .53 1.09 -1.60-1.90 
Depression 20   .48 1.15   -.90-3.00 
Somatization 20 1.26 1.51 -1.40-4.00 
     
OTHER     
Atypicality 20 1.05 1.29   -.60-5.20 
Withdrawal 20   .53   .89 -1.00-2.60 
Attention Problems* 20   .93 1.10 -1.10-2.70 
     
ADAPTIVE SKILLS 20 -1.17 1.32 -3.10-1.50 
Adaptability 20   -.63 1.36 -3.00-1.40 
Social Skills 20   -.48 1.19   1.90- .48 
Leadership 17   -.49 1.31 -2.80-1.60 
Activities of Daily Living 20 -1.32 1.22 -3.50-1.00 
Functional Communication 20 -1.36 1.49 -3.70-1.60 
          
Note. All scores reported in z-scores. 
*Used in multiple regression analysis      
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Table 9 Descriptive Statistics of Vineland-II 
    
 
 
          
Variables N         M         SD         Range 
          
ADAPTIVE BEHAVIOR COMPOSITEa 24 - 1.69 1.11 -4.40-   .00 
     
COMMUNICATIONa 24 - 1.37 1.29 -4.27-   .33 
Receptiveb 23 11.65 3.70  3.00-19.00 
Expressiveb 24 11.04 3.80  4.00-19.00 
Writtenb 24 11.46 3.41  5.00-17.00 
     
DAILY LIVING SKILLSa 24 -1.92 1.13 -4.40-   .33 
Personalb 24 10.29 3.64  4.00-18.00 
Domesticb 24 10.29 3.07  5.00-16.00 
Communityb 24   9.79 3.35  3.00-17.00 
     
SOCIALIZATIONa 24  -1.35 1.20 -3.73-   .67 
Interpersonal Relationsb 24 11.00 3.53  4.00-18.00 
Play and Leisure Timeb 24 10.58 3.67  4.00-17.00 
Coping Skillsb 24 12.33 3.43  7.00-19.00 
     
MOTOR SKILLSa  24  -1.86 1.36 -5.00- 1.13 
Gross Motor Skillsb 24   9.58 2.96  4.00-16.00 
Fine Motor Skillsb 24 11.13 4.33  1.00-20.00 
     
MALADAPTIVEc 23 18.00 2.49 14.00-16.00 
Internalizing Problemsc 24 18.67 2.30 15.00-24.00 
Externalizing Problemsc 24 16.62 3.29 12.00-24.00 
          
Note. aScores reported in z-scores.     
bAdaptive Scales reported in Vineland scaled scores: v-ss <13 is well-below to below average, 13-17 is low to 
high average, >17 is superior to very superior 
cMaladaptive scales reported in Vineland scaled scores: v-ss <18 is average, 18-20 is elevated, and >20 clinically 
elevated. 
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CHAPTER 4 
 RESULTS 
 
Predicting Biochemical Abnormalities with Processing Speed and Attention Measures 
 The primary hypotheses of this study explored associations across processing speed, 
attention measures, and biochemical abnormalities related to MD that were identified in these 
participants. 
Western Blot 
Standard multiple regression analyses were conducted with  processing speed and 
attention measure scores as predictor variables and total number of abnormal (at least one 
standard deviation below the control reference mean) DNA subunit/GADPH ratios associated 
with Complexes I through V as outcome variables.  A maximum of five abnormal ratios from 
Complex I (ND6), Complex II (30KDa), Complex III (Core 2), Complex IV (COX II), and 
Complex V (F1 alpha) were possible.  When the DAS-II Processing Speed Cluster and the 
BASC-II Attention Problem z-scores were used as predictor variables, the total variance 
explained by the model (Table 10) as a whole was 54.3%, F (2, 9) = 5.35, p = .03.  Processing 
speed was a significant predictor of the total number of abnormalities detected through the 
Western Blot (β = -.78, p = .02), as were attention problems (β = -.82, p = .02).  However, when 
a separate regression analysis was done using the NEPSY-II Auditory Attention Total Correct z-
score as a predictor variable, the model was not significant [F (2, 9) =.51, p =.62] and accounted 
for only 10.2% of the variance as shown in Table 11.     
Correlation analyses were performed in order to clarify the relationships among western 
blot complex ratios, processing speed, and attention.  No results were found to be significant as 
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shown in Table 12.  Independent-sample t-tests were also conducted to further compare 
performance on processing speed and attention tests for participants with normal and abnormal 
western blot subunit ratios.  The ratios were considered abnormal if the z-scores were equal to or 
below -1.  However, none of the t-test results reached significance.  Effect sizes were also small.    
Native Gels 
Multiple regression analysis was again used to determine how much variance in the total 
number of abnormal supercomplex and monomeric oxphos assemblies was accounted for by the 
processing speed and attention measures.  A maximum of six abnormalities was established 
through the combined Blue and Clear Native Gels.  The DAS-II Processing Speed Cluster and 
BASC-II Attention Problems measure scores together accounted for only 1% of the variance in 
the total number of abnormal complex assemblies [F (2,6) = .02, p =.98].  The DAS-II 
Processing Speed Cluster and NEPSY-II Auditory Attention scores also failed make significant 
contributions in a separate regression analysis [F(2,5) = .09, p = .09].  Lastly, participants with 
normal complex assemblies were compared to those with abnormal assemblies across all 
processing speed and attention measures using t-tests; however, none of the results reached 
significance.  
High Resolution Respirometry 
Multiple regression was used to determine how much variance in the total number of 
abnormal ratios and oxygen fluxes from high resolution respirometry assessment might be 
predicted by processing speed and attention measures.  A maximum of four abnormal ratios 
(uncoupling, net routine flux, respiratory control, and leak flux control) could result from the 
combined high resolution respirometry analysis of fibroblasts and skeletal muscle tissues.  The 
DAS-II Processing Speed Cluster and BASC-II Attention Problems did not account for a 
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significant proportion of the variance [F(2,5) = .30, p = .76].  The results from the regression 
model using the NEPSY-II Auditory Attention measure were also insignificant [F(2,6) = .15, p = 
.87] and accounted for only 4.7% of the total variance.       
 Correlations and t-tests were performed between the High Resolution Respirometry for 
skeletal muscle ratios, re-calculated as z-scores, and all of the standardized processing speed and 
attention measures.  Table 13 provides a summary of the correlational findings for High 
Resolution Respirometry of Skeletal Muscles.  A strong negative correlation was found between 
the succinate-supplemented media of skeletal muscles and NEPSY-II Auditory Attention (r  =  -
.75, p = .03).  Moreover, a significant group difference was found on the NEPSY-II Auditory 
Attention task between participants with normal (M = 0, SD = .89) and abnormal (M = -2.33, SD 
= .91) skeletal muscle succinate-supplemented media ratio; t (6) = 3.5, p = .012 (two-tailed).  
The magnitude of the differences in the means (mean difference = 2.33, 95% Cl: .72 to 3.95) was 
large (eta squared = .67).   
Nijmegen Criteria 
The Nijmegen criteria were used to investigate the relationships between the overall 
clinical and biochemical features of Mitochondrial Disease and processing speed and attention 
skills.  The Nijmegen criteria that were used to assess the children enrolled in the present study  
are provided in Appendix C.  Multiple regression assessed the ability of DAS-II Processing 
Speed Cluster and BASC-II Attention Problems to predict the Nijmegen Clinical Criteria Total 
score and Biochemical Criteria Total score in separate analyses.  The total variance of the 
Clinical Criteria explained by the model as a whole was only 3% [F(2, 16) =.23, p= .80] and not 
statistically significant.  The two independent variables also failed to reach statistical 
significance when predicting the Nijmegen Biochemical Criteria Total score [F(2,15) = .19, p = 
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.83].  Moreover, DAS-II Processing Speed Cluster and NEPSY-II Auditory Attention measures 
also failed to significantly account for the variance in the Clinical Criteria regression model 
[F(2,18) = .54, p = .59], as well as in the Biochemical Criteria model [F(2,18) = 1.48, p = .26].    
In order to better understand the relationships among all the Nijmegen Clinical criteria 
subdomains (neuromuscular manifestations, central nervous system and other organ 
involvement, metabolic and imaging studies, tissue morphology) and the primary cognitive 
measures of this study, correlation analyses were also conducted.  A summary of the results are 
presented in Table 14.  No significant correlations were found between the Nijmegen criteria and 
the primary cognitive measures.   
Supplementary Analyses  
Verbal Abilities 
Word Definition, Verbal Similarities, and Word Generation subtests were used to 
measure verbal abilities.  Aside from the group differences that were found for Succinate-
supplemented media ratios of skeletal muscle cells on DAS-II Verbal Cluster [t(6) = 3.23,  p = 
.02, eta squared = .63] using High Resolution Respirometry, no other findings reached 
significance across all areas. 
Visual-Spatial-Perceptual-Motor Functioning: 
The cognitive measures for this domain include the DAS-II Sequential and Quantitative 
Reasoning, DAS-II Pattern Construction, NEPSY-II Arrows, NEPSY-II Fingertip Tapping, and 
Imitating Hand Positions.  On Pattern Construction, a significant difference was found between 
participants with normal (M = -.52, SD =.91) and abnormal (M = -2.39, SD = 1.24) Complex II 
ratios using Western Blot; t(10) = 2.84, p =.02, eta squared = .45.  Correlation analysis revealed a 
significant association between Pattern Construction and High Resolution Respirometry total 
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abnormality score of skeletal muscle tissue (r = -.72, p = .04).  A significant, positive correlation 
was also found between Complex II ratio and NEPSY-II Imitating Hand Position (r = .58, p = 
.04), a motor task.   
Memory Functioning 
The DAS-II Recall of Digits Backward and Recall of Sequential Order Subtests 
combined to produce an overall Working Memory Cluster score in addition to the individual 
scores. There were group differences in DAS-II Working Memory Cluster [t (10) =2.70, p =.02, 
eta squared = .42] between normal (M = -.19, SD =.75) and abnormal (M = -1.99, SD= 1.52) 
Complex II groups using Western Blot. More group differences were found between normal (M 
= -.10, SD =.58) and abnormal (M = -1.76, SD = 1.36) Complex II groups for Recall of Digit 
Backwards [t (10) = 2.84, p =.02, eta squared =.45] as well between groups for Succinate-
supplemented media ratios of skeletal muscle on Recall of Sequential Order [t (5) = 2.54, p = 
.05, eta squared = .52].  A significant, positive correlation was found between Complex I ratio 
and DAS-II Recall of Digits Backwards (r =.59, p =.04), a working memory task using Western 
Blot.  
List Memory and Memory for Faces from the NEPSY-II were also administered to 
measure memory and learning.  No significant relationship was found between these measures 
and biochemical/medical indices.     
Executive Functioning 
The Auditory Response Set, Design Fluency, and Inhibition subtests from the NEPSY-II 
were administered as measures of executive functioning.  On the Western Blot, a significant 
difference in scores was also found on the Response Set Total Correct between participants with 
normal (M = -2.22, SD = 1.20) and abnormal (M = -.83, SD = .24) ratios for Complex IV; t (6) = 
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-2.67, p=.027 (two-tailed).  There was a large difference in the means; eta squared = .54, mean z-
score difference = -1.39, 95% Cl: -2.67 to -1.09. Moreover, a positive correlation was found 
between the Complex II ratio and NEPSY-II Design Fluency (r =.66, p =.01).  In support of this 
finding, there was a significant difference on the NEPSY-II Design Fluency scores between 
participants with normal (M = -.50, SD = .64) and abnormal (M = -2.29, SD = .52) Complex II 
ratios; t (9) = 1.79, p = .001.  The magnitude of the differences in the means (mean z-score 
difference = 1.79, 95% Cl: .99 to 2.59) was also large (eta squared = .26).   In addition, strong 
negative correlations were found between leak flux ratio and NEPSY-II Inhibition-Naming 
Completion Time (rho = -.74, p = .04), and respiratory control ratio and NEPSY-II Inhibition-
Naming Completion Time (rho = -.74, p= .04).  No results reached significance with any of the 
Nijmegen and Native Gel measures.   
Social Perception 
 No findings reached significance when correlations and t-tests were conducted between 
biochemical/medical indices and the NEPSY-II Affect Recognition Subtest. 
Behavioral and Adaptive Functioning 
A significant difference in scores was found on BASC-II Internalizing Problems [t (10) = 
3.08, p = .01, eta squared = .49] between participants with normal (M = .89, SD = 1.43) and 
abnormal (M = -.50, SD = 0) Complex IV ratios on the Western Blot.  Likewise, group 
differences were found on High Resolution Respirometry Succinate-supplemented media ratios 
of skeletal muscle cells, specifically on BASC-II internalizing problems [t (5) = 3.20, p = .03, eta 
squared = .67] and BASC-II Depression [t (5) = 3.42, p = .02, eta squared = .70].  With t-test 
analyses, significant group differences were found in the BASC-II Behavioral Symptoms Index 
scores between participants with normal and abnormal ratios assessing oxygen consumption with 
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the addition of ADP using High Resolution Respirometry in skeletal muscles; t(5) = 4.05, p = 
.01, eta squared = .77.  Furthermore, significant associations were found between Nijmegen 
Neuromuscular Manifestations and BASC-II Withdrawal (r = -.48, p = .03), and Nijmegen Total 
Biochemical Criteria and BASC-II Withdrawal (r = -.66, p = .002).  
In regards to Adaptive Functioning, t-test analyses evaluating group differences for 
Complex I ratios revealed a significant difference in scores on BASC-II Adaptability between 
participants with normal (M=-1.76, SD=1.21) and abnormal (M =-.09, SD = 1.08) complexes [t 
(10) = -2.52, p = .03, eta squared  = .67] using the Western Blot.  Also, On the Nijmegen, 
significant associations were found between Total Biochemical Criteria and BASC-II 
Adaptability (r = -.44, p = .05). Significant difference was found on the Vineland Receptive 
subdomain for participants with normal (“Possible/Unlikely”) and abnormal (“Highly Probable/ 
Probable) Total Biochemical Criteria [t (19) = 2.69, p = .01; eta squared = .28].   Also, group 
differences were found between participants with and without genetic mutation in the parent 
ratings of BASC-II Functional Communication [t (14) = 2.46, p = .027; eta squared = .29] and 
Vineland-II Coping Skills [t (17) = 2.16, p = .05; eta squared = .22].   
Academic Achievement 
No findings reached statistical significance when correlations and t-tests were conducted 
among biochemical/medical indices, WIAT-II Word Reading, and Numerical Operation. 
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Table 10 Multiple Regression Analyses using BASC-II Attention Problems 
             
Biochemical Measures N B β p  R Square 
              
WESTERN BLOT TOTAL ABNORMALITYa  15      
Model    .03*  .54 
DAS Processing Speed  22   -.86 -.78 .02*   
BASC Attention Problems 20 -1.45 -.82 .02*   
NATIVE GEL TOTAL ABNORMALITYa 11           
Model    .98  .01 
DAS Processing Speed  22 -.05 -.06 .92   
BASC Attention Problems 20  .05  .04 .95   
HIGH RESOLUTION TOTAL ABNORMALITYa  10      
Model    .76  .11 
DAS Processing Speed  22 -.15 -.15 .78   
BASC Attention Problems 20 -.62 -.39 .48   
NIJMEGEN TOTAL CLINICAL SCOREa 25      
Model    .80  .03 
DAS Processing Speed  22 -.06 -.05 .88   
BASC Attention Problems 20 -.38 -.19 .53   
NIJMEGEN TOTAL BIOCHEMICAL SCOREa  23      
Model    .83  .03 
DAS Processing Speed  22 .09 .17 .58   
BASC Attention Problems 20 .03 .03 .92   
 
Note. aDependent variables. ** Significant at the 0.01 level. * Significant at the 0.05 level. 
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Table 11 Multiple Regression Analyses using NEPSY-II Auditory Attention 
             
Biochemical Measures N B β p  R Square 
              
WESTERN BLOT TOTAL ABNORMALITYa  15     .10 
Model      .62   
DAS Processing Speed  22  -.45 .58  -.41   
NEPSY Auditory Attention 21   .15 .66   .13   
NATIVE GEL TOTAL ABNORMALITYa 11      
Model    .92  .03 
DAS Processing Speed  22 -.24 -.29 .70   
NEPSY Auditory Attention 21 .26  .28 .72   
HIGH RESOLUTION TOTAL ABNORMALITYa  10      
Model    .87  .05 
DAS Processing Speed  22 .33  .34 .63   
NEPSY Auditory Attention 21 .38 -.34 .62   
NIJMEGEN TOTAL CLINICAL SCOREa 25      
Model    .59  .06 
DAS Processing Speed  22  .01  .02 .96   
NEPSY Auditory Attention 21 -.12 -.25 .51   
NIJMEGEN TOTAL BIOCHEMICAL SCOREa  25      
Model    .26  .14 
DAS Processing Speed  22 -.22 -.25 .49   
NEPSY Auditory Attention 21 -.14 -.14 .69   
 
Note. aDependent variables. ** Significant at the 0.01 level. * Significant at the 0.05 level. 
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Table 12 Correlations across Western Blot (N=15), Processing Speed, and Attention 
                  
            Complex Type     Total Abnormalities 
 I II IIIa IV V  Based on z-score 
                
PROCESSING SPEED         
Processing Speed Cluster .51 .35 .20 .41 -.15  -.35 
Speed of Information Processing .48 .51 .19 .38  .02  -.29 
Rapid Naming   .42 .27 .21 .26 -.22  -.32 
        
ATTENTION         
Auditory Attention Correct .45 .06 .10 .43  .00  -.18 
BASC-II Attention Problems .26 .04 .46 .00 -.44  -.42 
 
Note. ** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 level (2-tailed).  
aSpearman's correlation was used instead of Pearson's because the distribution was not normal 
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Table 13 Correlations across Skeletal Muscles High Resolution Respirometry (N=9), Processing Speed, and Attention 
               
 UCR NRF RCR LFCa GMADP Succinate Total Abnormality 
               
PROCESSING SPEED         
Processing Speed Cluster .15 -.06 -.07  -.19 -.06 -.21 -.13 
Speed of Information Processing .06  .02 -.08  -.05  .08 -.07  .05 
Rapid Naming   .19 -.10 -.06  -.24 -.16 -.31 -.26 
        
ATTENTION         
Auditory Attention Total Correct .36 -.24  .39 -.48 -.44 -.75* -.41 
BASC-II attention Problems .42 -.40 -.41  .05 -.17 -.02 -.17 
Note.  UCR=Uncoupling Ratio; NRF=Net Routine Flux, RCR=Respiratory Control Ratio; LFC= Leak Flux Control, 
 RCRp=Phosphorylation Respiratory Control; GMADP= Glutamate +Malate+ADP.  
aSpearman's correlation was used instead of Pearson's because the distribution was not normal 
** Correlation is significant at the 0.01 level (2-tailed).  
* Correlation is significant at the 0.05 level (2-tailed). 
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Table 14 Correlations across Nijmegen Criteria, Processing Speed, and Attention Measures 
 
        
  Clinical Criteria    Total 
 
Neuro-
muscular 
CNS/ 
Organs 
Metabolic/ 
Imaging Tissue  Clinical Biochemical 
        
        
PROCESSING SPEED        
Processing Speed Cluster .16 -.31 -.03 -.05  -.01 -.13 
Speed of Information Processing .08 -.29 .06 -.11  -.01 -.39 
Rapid Naming .17 -.23 .17  .09   .13 -.29 
        
ATTENTION        
Auditory Attention Total Correct .04 -.09  .14  .04   .14 -.33 
BASC-II Attention Problems .01  .31 -.32 -.15  -.16  .27 
        
 
              
 
 
    
 
Note. ** Correlation is significant at the 0.01 level (2-tailed).  * Correlation is significant at the 0.05 level (2-ta
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CHAPTER 5 
 DISCUSSION 
 
The overarching goal of the current study was to examine relationships among medical 
indices, biochemical measures, and neurobehavioral functioning of children with mitochondrial 
disorders.  The laboratory biochemical tools and medical data that were used in this study 
consisted of the Western Blot, Native Gels, High Resolution Respirometry, and the Nijmegen 
screening criteria.  The findings from these laboratory methods were assessed in relation to 
children’s processing speed and attention based on the prediction that impaired functioning of 
proteins, complexes, and cellular respiration, that are critical in ATP production, will impact 
neurodevelopment and related neuropsychological processes in children with MD.  
Supplementary analyses were also conducted to examine relationships among these laboratory 
measures, diagnostic indices, and other cognitive measures to evaluate whether other 
explanations were warranted.  
Based on maturational theories of brain development and what is known about brain 
metabolic activity from infancy to early childhood, it was predicted that subcortical and posterior 
areas in the brain, and related white matter connections, would more likely be interrupted by 
MD.  Moreover, based on the neuropsychological sequalae observed in other subcortical and 
white matter diseases, and brain insults in infancy and early childhood, it was hypothesized that 
children with MD would show deficits in processing speed and attention, which could underlie 
the delays or deficits in higher order cognitive functions reported in some cases of MD.  
As predicted, both DAS-II Processing Speed Cluster and BASC-II Attention Problems 
were significant predictors of the total number of abnormal Complex (I through V) proteins 
detected through Western Blot analysis.  Regression with other cognitive measures, such as 
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measured by the DAS-II Verbal Cluster, DAS-II Working Memory, DAS-II Pattern 
Construction, and BASC-II Adaptive Skills, did not show this relationship.  These findings 
suggest that poor processing speed and attention-related problems may be markers of abnormal 
protein expression of complexes that are central in the oxidative phosphorylation process.  The 
early onset of the disease process, specifically the impaired production of ATP, may disrupt 
typical development of brain regions that subserve these processing speed and attentional 
systems.   
In contrast to the above relationships, however, processing speed and attention measures 
were not predictive of other biochemical or medical indices.  These predictor variables failed to 
account for a significant portion of the variance in the Native Gels, High Resolution 
Respirometry, or Nijmegen Criteria variables.  This raises the question of why the relationship 
exists for the Western Blot but not for other biochemical or medical indices.  One possible 
explanation is that the Western Blot, Native Gels, and High Resolution Respirometry are 
laboratory tools that measure different aspects of mitochondrial dysfunction.  Processing speed 
and attention may be more sensitive to the differences at the level of protein expression, as 
measured by the Western Blot, compared to differences at the level of multiprotein (Native Gels) 
or cellular respiration (High Resolution Respirometry).      
It is possible that the significant result with the Western Blot is just a false-positive 
finding given that most of the relationships measured among processing speed, attention, and 
other biochemical or medical  measures indices were statistically insignificant.  However, the 
sole finding with the Western Blot may partly be explained by the better reliability and higher 
sensitivity of using this technique compared to others which had a number of measurement-
related limitations.  For instance, abnormalities on the Native Gels were detected based on a 
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qualitative assessment (visual detection of abnormalities) as opposed to using normed values like 
in the Western Blot.  While variables from High Resolution Respirometry were based on 
quantitative values, the sample size was much smaller than the Western Blot.   Moreover, the 
Nijmegen criteria, as medical indices that cover a wide array of disease-related manifestations, 
may have been too broad and not sensitive enough to capture the subtle differences on these 
cognitive measures.   
Based on findings that suggest that processing speed and attention may be markers for at 
least certain biochemical dysfunction in MD, additional analyses were performed with other 
cognitive measures, which were not originally hypothesized to be related, to evaluate whether 
these findings were representative of more global deficit relationships, or different explanations 
were warranted.  No other regression analysis revealed significant findings.  However, 
explorative analyses showed some deficit relationship between biochemical/medical indices and 
areas of executive function, working memory, internalizing behavioral problems, and 
adaptability.   
A number of relationships were found between biochemical/medical indices and 
measures constructed to assess different aspects of executive function. Specifically, there were 
significant associations between the Western Blot and NEPSY-II Response set Total Correct 
score, Western Blot and NEPSY-II Design Fluency, and High Resolution Respirometry and 
NEPSY-II Inhibition Naming Total Completion Time.  Whereas the Inhibition Naming 
Completion Time can be argued to provide a better measure of processing speed, since the task 
simply measures the ability to rapidly name shapes and direction of arrows, the relationships 
with the Response Set and Design Fluency tasks were less expected.  Furthermore, the 
associations found among Western Blot measures, DAS-II Recall of Digits Backward, and DAS-
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II Recall of Sequential Order were notable when considering that working memory has been 
suggested to be a component of executive functions (Garon, Bryson, & Smith, 2008).   In light of 
these findings, it is important to explore the interrelationships between executive functions and 
more basic attentional systems and the possible impact of mitochondrial dysfunction on this 
network. 
A central question, at base, is whether the cognitive framework for understanding 
mitochondrial dysfunction is one of poor executive control or of compromised lower-order 
attentional processes.  Currently, attention is regarded as a network of interrelated processes that 
include the properties of selection and control (Burack & Enns, 1997).  These attentional 
properties are thought to be implemented in networks that are hierarchically organized into two 
distinct levels (Posner & Petersen, 1990).  Basic attentional processes, referred to as the posterior 
attentional systems, are deployed quickly and automatically and usually recruit related system 
necessary for goal-directed actions.  Higher-executive functions, also known as the anterior or 
supervisory attentional system, provide direction and focus for the operations subserved by the 
posterior system.   
When attention is conceived as a basic building block for the executive function system, 
it is suggested that attention problems at any point in development will affect emerging executive 
function abilities (Garon, Bryson, & Smith, 2008).  For instance, children with attention 
problems show deficits in many executive function tasks when compared to typically developing 
children, as revealed in a number of studies of children with ADHD (Semrud-Clikeman, 
Walkowiak, Wilkinson, & Butcher, 2010).   Furthermore, a hierarchical model of 
neurodevelopment suggests that early brain damage may have a significant impact on attention 
development with more global of diffuse implications for later executive function abilities.  
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Therefore, the understanding that anterior executive functions depend on the efficient execution 
of the lower-order attentional system, provides a possible explanation for the significant 
associations found between measures of oxidative phosphorylation dysfunction and measures of 
executive function in the present study. 
Findings from the current study suggest that mitochondrial disease may also 
detrimentally impact behavior, as implicated by associations found between biochemical and 
medical indices and measures of internalizing problems, withdrawal, and adaptability.  In some 
regard, it is not surprising that a chronic medical condition, that is known to cause an array of 
physical and cognitive limitations, will impact how these children perceive themselves and how 
they choose to interact with others.  In fact, the increased risk of major depressive disorder and difficulties in social functioning in children with a chronic medical condition has been well documented in the literature (Curtis & Luby, 2008).  Moreover, medical conditions that restrict physical activities or require frequent absences have been associated with social problems, such as being ignored or teased by peers (Lightfoot, Wright, & Sloper, 
1999). 
Collectively from the study findings, it is unclear whether or not speeded processing and 
attention are significantly more impacted by biochemical features of MD than other 
neurocognitive domains.  The association found with the Western Blot may reflect the impact 
that abnormal proteins, that are critical for ATP production, have on processing speed and 
attention.  The significant finding, however, may be also a result of Type I error.       
There were a number of considerations when evaluating the study findings.  For instance, 
there were a number of sample-related limitations. First, most of the participants were of average 
to above average SES and were Caucasian. Therefore, it is unknown how well these findings, 
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particularly performance on cognitive measures and parent ratings of behavior and adaptive 
functioning, may generalize to the larger population of MD patients.  Second, it is unknown 
whether parents of children who were higher functioning, compared to parents of children with 
lower function or greater impairment, may have been more or less invested in participating in 
this study.  Most importantly, the sample size for this study was limited due to the rarity of this 
condition and children’s availability for testing; this was amplified because of missing 
biochemical data, which limited the extent of regression analyses that could be conducted.   
There were also a number of measurement-related limitations to the current study.  Most 
of the attention and processing speed measures had fine motor or oromotor components, which 
may have slowed the children’s performance on these tasks.  For instance, 76% of the 
participants in this study were reported to have motor and muscle-related problems, such as poor 
balance, motor coordination and strength, and fine motor dexterity.  The average participant was 
rated to have low Motor Skills on the Vineland-II.   In addition, some of the children in this 
study were clearly limited in their language skills, which most likely impacted their abilities to 
understand some of the more verbal tasks.  It is possible that the inclusion of all participants in 
our analyses, including those who were too impaired to do most of the tasks, may have washed 
out any subtle distinctions that may have been present for the more functioning children.  With a 
larger sample, statistical analyses could have been controlled for verbal and fine motor skills, 
which may be potential confounds in this study.  Moreover, with a larger sample size, it would 
have been possible to create a separate group of children who were too severely impaired to be 
reliably assessed.   
Another major issue in this study was mental fatigue.  Some of the participants were 
observed to struggle even when breaks were frequently provided.   However, an attempt was 
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made to minimize the effects of fatigue by testing all participants, with the exclusion of one, in 
the morning and administering the tests in the same order to make the effects of fatigue more 
consistent among participants.          
Conclusion 
The current study provides some support for the primary hypotheses that processing 
speed and attention are markers of abnormal protein expression that interferes with the 
production of ATP in the oxidative phosphorylation process.  To date, no published study has 
investigated relationships among standardized biochemical features, neuropsychological 
outcomes, and established diagnostic criteria of Mitochondrial Disease.  This study further 
highlights the level of heterogeneity that exists in the clinical presentation of Mitochondrial 
Disease. Further studies are needed to better establish relationships between the large spectra of 
symptoms presented and the underlying neurogenetic and biochemical processes.  
Although neural abnormalities, particularly white matter anomalies, have been linked 
with mitochondrial disease, there is little empirical evidence that elucidates how these 
abnormalities relate to cognition in this population.  Diffusion tensor imaging (DTI) is a new 
MRI technique that provides non-invasive information about the integrity of white matter by 
quantitatively analyzing the directionality of axonal fibers (White et al., 2008).  DTI has been 
found to be highly sensitive to subtle white matter abnormalities in neurogenerative disease, even 
in early stages at which they may be undetectable via conventional MRI.  Functional 
neuroimaging will facilitate further elucidation of the brain-behavior relationships in MD.   
Given the wide spectrum of cognitive functioning observed in this study, future studies 
may also benefit from splitting participants with severe impediments in language functioning or 
fine motor abilities from those who are higher functioning to capture the subtle relationships 
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between cognitive and biochemical measures.  For instance, participants could be screened using 
parent ratings on the Vineland-II Functional Communication and Fine Motor Skills.  Assessment 
of children with severe cognitive deficits could be conducted using measures that have lower 
basal items or relying on parent questionnaires.  Lastly, there is a strong need to conduct 
longitudinal studies to capture the progression of cognitive changes and, at times, loss of 
acquired skills that is reported in clinical settings but have yet to be well-studied with a large 
group of patients.  
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 Nijmegen Clinical Criteria for Mitochondrial Disease 
 
CLINICAL CRITERIA SCORE 
Neuromuscular manifestations (Maximum of 2 points) 
 
 
a. Progressive external ophthalmoplegia (2 points)  
b. Ptosis (1 point)  
c. Exercise intolerance (1 point)  
d. Muscle weakness (1 point)  
e. Rhabdomyolysis (1 point)  
f. Abnormal electromyogram (1 point)  
Central nervous system and other organ involvement (Maximum of 2 points)  
g. Isolated central nervous system involvement (1 point)  
h. Any other isolated organ system (1 point)  
i. Two or more organ systems (2 points)  
Metabolic and imaging studies (Maximum of 4 points)  
j. Elevated blood lactate on 3 occasions (2 points)  
k. Elevated cerebrospinal fluid lactate (2 points)  
l. Elevated blood alanine (2 points)  
m. Elevated cerebrospinal fluid alanine (2 points)  
n. Elevated urine tricarboxylic acid (Kreb) cycle intermediates (2 points)  
o. Elevated urine ethylmalonic, 3-methylglutcaonic, or dicarboxylic 
acids (1 point) 
 
p. Abnormal 31P-MRS (magnetic resonance spectroscopy)  in muscle 
with reduced Phosphocreatine/Pi ratio (2 points) 
 
q. Abnormal T2 signal in basal ganglia on brain MRI (2 points)  
r. Decreased resting metabolic rate or abnormal exercise studies (cycle 
ergometry protocol) (2 points) 
 
Tissue morphology (Maximum of 4 points)  
s. Ragged red fibers on muscle biopsy (2 points if present, 4 points if 
>2%) 
 
t. Diffuse reduction in cytochrome c oxidase histochemical reaction or 
scattered COX deficient fibers(4 points) 
 
u. Strongly succinate dehydrogenase positive vessels  by 
histochemistry (1 point) 
 
v. Abnormal mitochondria by electron microscopy (2 
points) 
 
TOTAL   
Scoring for evaluation of Clinical Criteria: 
 Highly probable: 8-12 points 
 Probable: 5-7 points 
 Possible: 2-4 points 
Unlikely: 1 point 
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Nijmegen Biochemical and Genetic Criteria for Mitochondrial Disease 
 
 
BIOCHEMICAL CRITERIA SCORE 
1. Abnormal high resolution respirometry  in muscle or fibroblasts (measurements 
<5% reference level) (Live (fresh tissue) assessment of Complex V function, 
coupling and protein leak across the mitochondrial membrane:) 
 
2. Abnormal OXPHOS subunit immunohistochemistry or immunofluorescece in 
skeletal muscle tissue sections (Qualitative assessment of OXPHOS enzyme 
assembly within tissue sections. Defects in OXPHOS enzyme assembly are 
readily recognized by this testing.) 
 
3. Abnormal OXPHOS enzymology (single or multiple enzyme defects)  (activity 
measurements <5% reference level) (Testing must be performed on 
mitochondria isolated from fresh (not frozen) tissue to minimize risk of artifacts 
caused by freezing skeletal muscle prior to mitochondrial isolation). 
 
4. Abnormal quantitative Western Blot of Selected OXPHOS subunits from 
Complexes I-V (levels <5% reference level for subunit) (Western blot can detect 
defects that are not evident by other techniques. (Oglesbee, Freedenberg, 
Kramer, Anderson, & Hahn, 2006)) 
 
5. Abnormal muscle CoQ10 level (<50% of control mean) (Allows assessment for 
primary defects in Coenzyme Q10 synthesis. (Lopez, et al., 2006))  
 
6. Supercomplex evaluation: Optimal OXPHOS function requires aggregation of 
individual OXPHOS enzymes into supercomplexes which allows efficient and 
rapid transport of electrons. (Ardehali, Chen, Ko, Mejia-Alvarez, & Marban, 
2004; Bianchi, Genova, Parenti Castelli, & Lenaz, 2004; Dudkina, Eubel, 
Keegstra, Boekema, & Braun, 2005; Genova, Bianchi, & Lenaz, 2003; 
Schluesener, Rogner, & Poetsch, 2007) Supercomplexes allow efficient 
formation of an electrochemical (proton) gradient created by Complexes I, III, 
and IV that is then used by Complex V to synthesize ATP. Supercomplex 
formation is impaired in a variety of OXPHOS diseases. (Acin-Perez, 
Fernandez-Silva, Peleato, Perez-Martos, & Enriquez, 2008; Cortes-Hernandez, 
Vazquez-Memije, & Garcia, 2007; De Meirleir, et al., 2004; Diaz, Fukui, Garcia, 
& Moraes, 2006; Gerards, et al., 2009; Jesina, et al., 2004; Jonckheere, et al., 
2008; Kirby, et al., 2003; Mayr, et al., 2008; Moreno-Loshuertos, et al., 2006; 
Roels, et al., 2009; Sasarman, Antonicka, & Shoubridge, 2008; Smet, et al., 
2009; Ugalde, Janssen, van den Heuvel, Smeitink, & Nijtmans, 2004; Williams, 
Valnot, Rustin, & Taanman, 2004) 
 
a. Abnormal supercomplex formation (Score 0.5 if present only in Blue 
Native OR OXPHOS Clear Native Immunoblot. Score 1 if present in 
BOTH tests.) 
 
b. Abnormal monomeric OXPHOS enzyme complex formation (Score 
0.5 if present only in Blue Native OR OXPHOS Clear Native 
Immunoblot. Score 1 if present in BOTH tests.) 
 
7. Abnormal in-gel OXPHOS enzyme  activity. (Qualitative in-gel assessment of 
OXPHOS enzyme activity in intact enzymes. This is particularly important in 
assessment of the ATPase activity of Complex V and Complex V assembly. 
(Cortes-Hernandez, et al., 2007; De Meirleir, et al., 2004; Jesina, et al., 2004; 
Jonckheere, et al., 2008; Smet, et al., 2009)) 
 
TOTAL SCORE  
Scoring for evaluation of Biochemical Criteria 
 Unlikely: Criteria - A-H are normal 
Possible: Criteria – a single test is abnormal and the rest are normal or equivocal 
Probable: Criteria- Two tests are abnormal.  
Highly Probable: >2 abnormal tests   
 
GENETIC CRITERIA SCORE 
1. mtDNA depletion (mtDNA copy number <5% reference interval)  
2. Identification of confirmed pathogenic mtDNA or nuclear DNA mutation  
3. Identification of provisional pathogenic mtDNA or nuclear DNA mutation (i.e. mutation 
requires additional data supporting pathogenicity) 
 
4. No mutation identified  
Scoring for evaluation of Genetic Criteria 
Definite: Criteria 1 or 2 are abnormal 
Probable: Criteria for 3 is abnormal 
Undetermined: Criteria 4 is present 
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Around 90 proteins have been identified that are critical in the oxidative phosphorylation 
process (Smits, Smeitink, & van den Heuvel, 2010).  MD is caused by pathogenic mutations in 
nuclear or mitochondrial DNA that encode these proteins.  In MD, nuclear DNA (nDNA) 
mutations are passed down by autosomal recessive, autosomal dominant, X-linked, or, more 
rarely, isodisomy (chromosomes in a pair are inherited from one parent ) mechanism 
(Shoubridge, 2001).   Mitchondrial DNA (mtDNA) is different from nDNA in that it can only be 
inherited maternally.  A mixture of normal and abnormal mtDNAs can be present in MD.   
Understanding the variable nature of the genotype-phenotype relationship in MD  is a 
challenging process (Smits, et al., 2010).  For instance, the same mutation in a gene can present 
with very different clinical manifestations, whereas the same clinical phenotype can be caused by 
different mutations (Bernier, et al., 2002; Lamont, et al., 1998). The variability in symptoms may 
be due to several factors, including the ratio of wild-type to mutant mtDNA, varying thresholds 
of biochemical expression for both the mutation and the tissue involved, and the controlling 
effect of nuclear and other mitochondrial genes (Leonard & Schapira, 2000).  Given that studies 
are still underway to locate the genes that are responsible for mitochondrial dysfunction, the 
identification of a pathogenic mutation is not required in the diagnosis of MD as long as there is 
sufficient evidence of clinical and biochemical anomalies related to oxphos defects (Morava, et 
al., 2006).     
 The Table below provides a summary of the individual roles the different complexes play 
in ATP production.   
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Complex I Removes electrons from NADH and transfers them to 
ubiquionone, a lipid-soluble carrier.  It is also responsible 
for moving protons across the membrane to produce a 
proton gradient. 
Complex II Serves to channel additional electrons into the quinone 
pool by removing electrons from electron donors, such as 
succinate, and transferring them to ubiquinone. 
Complex III Removes electrons from ubiquinol, which is the reduced 
product from Complex I, and transfers them to 
cytochrome c, a water-soluble electron carrier located 
within the inter-membrane space When electron transfer 
is delayed by a high membrane potential, point mutations, 
or respiratory inhibitors, Complex III leaks electrons to 
oxygen resulting in the formation of highly toxic 
superoxide, which is thought to contribute to the 
pathology of a number of diseases.  
 
Complex IV Involved in removing electrons from cytochrome c and 
transferring them to molecular oxygen, producing 
molecules of water.  Furthermore, it contributes to the 
proton gradient by moving protons across the membrane.   
Complex V As the protons pass through Complex V, the osmotic 
energy of the gradient is converted into chemical energy 
in the form of ATP.  This transmembrane proton gradient 
is used to drive the endergonic reaction of ATP synthesis. 
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Appendix C 
 
List of Tests Administered Based on Age  
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Tests Administered 
    
DOMAIN/Subtests Administered Ages 
    
  
PROCESSING SPEED  
Speed of Information Processing (DAS-II)  5-13 
 Rapid Naming (DAS-II)  5-13 
  
ATTENTION  
Auditory Attention (NEPSY-II)  5-12 
 
EXECUTIVE FUNCTIONING 
Response Set (NEPSY-II) 5-12 
Inhibition (NEPSY-II)   
     Naming 5-13 
     Inhibition 5-13 
     Switching 7-13 
Design Fluency (NEPSY-II)  5-13 
 
VERBAL COMPREHENSION  
 Word Definition (DAS-II)  5-13 
Verbal Similarities (DAS-II)  5-13 
  
PERCEPTUAL REASONING  
Sequential Quantitative Reasoning (DAS-II)  5-13 
Pattern Construction (DAS-II)  4-13 
 
WORKING MEMORY  
Recall of Sequential Order (DAS-II)  5-13 
Recall of Digits Backwards (DAS-II)  5-13 
  
VISUAL AND SENSORIMOTOR  
 Arrows (NEPSY-II)  5-13 
 Fingertip Tapping (NEPSY-II)  5-13 
Imitating Hand Positions (NEPSY-II)  4-12 
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WORD RETRIEVAL  
Word Generation (NEPSY-II)   
     Semantic 4-13 
      Initial Letter 7-13 
  
MEMORY   
 List Memory (NEPSY-II)  7-12 
Memory for Faces (NEPSY-II)  7-12 
 
SOCIAL PERCEPTION  
Affect Recognition (NEPSY-II)  4-13 
  
READING  
Word Reading (WIAT-II)  4-13 
 
MATH  
Numerical Operations (WIAT-II)  5-13 
 
 
